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A B S T R A C T
Background
Guidelines have provided positive recommendations for pulmonary rehabilitation after exacerbations of chronic obstructive pulmonary
disease (COPD), but recent studies indicate that postexacerbation rehabilitation may not always be effective in patients with unstable
COPD.
Objectives
To assess effects of pulmonary rehabilitation after COPD exacerbations on hospital admissions (primary outcome) and other patient-
important outcomes (mortality, health-related quality of life (HRQL) and exercise capacity).
Search methods
We identified studies through searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase,
PEDro (Physiotherapy Evidence Database) and the Cochrane Airways Review Group Register of Trials. Searches were current as of 20
October 2015, and handsearches were run up to 5 April 2016.
Selection criteria
Randomised controlled trials (RCTs) comparing pulmonary rehabilitation of any duration after exacerbation of COPD versus conven-
tional care. Pulmonary rehabilitation programmes had to include at least physical exercise (endurance or strength exercise, or both).
We did not apply a criterion for the minimum number of exercise sessions a rehabilitation programme had to offer to be included in
the review. Control groups received conventional community care without rehabilitation.
Data collection and analysis
We expected substantial heterogeneity across trials in terms of how extensive rehabilitation programmes were (i.e. in terms of number
of completed exercise sessions; type, intensity and supervision of exercise training; and patient education), duration of follow-up (< 3
months vs ≥ 3 months) and risk of bias (generation of random sequence, concealment of random allocation and blinding); therefore,
we performed subgroup analyses that were defined before we carried them out. We used standard methods expected by Cochrane in
preparing this update, and we used GRADE for assessing the quality of evidence.
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Main results
For this update, we added 11 studies and included a total of 20 studies (1477 participants). Rehabilitation programmes showed great
diversity in terms of exercise training (number of completed exercise sessions; type, intensity and supervision), patient education (from
none to extensive self-management programmes) and how they were organised (within one setting, e.g. pulmonary rehabilitation,
to across several settings, e.g. hospital, outpatient centre and home). In eight studies, participants completed extensive pulmonary
rehabilitation, and in 12 studies, participants completed pulmonary rehabilitation ranging from not extensive to moderately extensive.
Eight studies involving 810 participants contributed data on hospital readmissions. Moderate-quality evidence indicates that pulmonary
rehabilitation reduced hospital readmissions (pooled odds ratio (OR) 0.44, 95% confidence interval (CI) 0.21 to 0.91), but results were
heterogenous (I2 = 77%). Extensiveness of rehabilitation programmes and risk of bias may offer an explanation for the heterogeneity,
but subgroup analyses were not statistically significant (P values for subgroup effects were between 0.07 and 0.11). Six studies including
670 participants contributed data on mortality. The quality of evidence was low, and the meta-analysis did not show a statistically
significant effect of rehabilitation on mortality (pooled OR 0.68, 95% CI 0.28 to 1.67). Again, results were heterogenous (I2 = 59%).
Subgroup analyses showed statistically significant differences in subgroup effects between trialswithmore and less extensive rehabilitation
programmes and between trials at low and high risk for bias, indicating possible explanations for the heterogeneity.Hospital readmissions
and mortality studies newly included in this update showed, on average, significantly smaller effects of rehabilitation than were seen in
earlier studies.
High-quality evidence suggests that pulmonary rehabilitation after an exacerbation improves health-related quality of life. The eight
studies that used St George’s Respiratory Questionnaire (SGRQ) reported a statistically significant effect on SGRQ total score, which
was above the minimal important difference (MID) of four points (mean difference (MD) -7.80, 95% CI -12.12 to -3.47; I2 = 64%).
Investigators also noted statistically significant and important effects (greater than MID) for the impact and activities domains of the
SGRQ. Effects were not statistically significant for the SGRQ symptoms domain. Again, all of these analyses showed heterogeneity, but
most studies showed positive effects of pulmonary rehabilitation, some studies showed large effects and others smaller but statistically
significant effects. Trials at high risk of bias because of lack of concealment of random allocation showed statistically significantly larger
effects on the SGRQ than trials at low risk of bias. High-quality evidence shows that six-minute walk distance (6MWD) improved,
on average, by 62 meters (95% CI 38 to 86; I2 = 87%). Heterogeneity was driven particularly by differences between studies showing
very large effects and studies showing smaller but statistically significant effects. For both health-related quality of life and exercise
capacity, studies newly included in this update showed, on average, smaller effects of rehabilitation than were seen in earlier studies,
but the overall results of this review have not changed to an important extent compared with results reported in the earlier version of
this review.
Five studies involving 278 participants explicitly recorded adverse events, four studies reported no adverse events during rehabilitation
programmes and one study reported one serious event.
Authors’ conclusions
Overall, evidence of high quality shows moderate to large effects of rehabilitation on health-related quality of life and exercise capacity
in patients with COPD after an exacerbation. Some recent studies showed no benefit of rehabilitation on hospital readmissions and
mortality and introduced heterogeneity as compared with the last update of this review. Such heterogeneity of effects on hospital
readmissions andmortalitymay be explained to some extent by the extensiveness of rehabilitationprogrammes andby themethodological
quality of the included studies. Future researchers must investigate how the extent of rehabilitation programmes in terms of exercise
sessions, self-management education and other components affects the outcomes, and how the organisation of such programmes within
specific healthcare systems determines their effects after COPD exacerbations on hospital readmissions and mortality.
P L A I N L A N G U A G E S U M M A R Y
Pulmonary rehabilitation for people who have been in hospital with an exacerbation of chronic obstructive pulmonary disease
Review question:Wewished to compare the impact of pulmonary rehabilitation after an exacerbation of chronic obstructive pulmonary
disease (COPD) on hospital readmissions and other patient-important outcomes such as quality of life versus usual post-exacerbation
care.
Study characteristics: We included 20 studies involving 1477 participants with COPD. Rehabilitation programmes started in hospital
in some trials and after discharge in others. These programmes showed great diversity in terms of exercise training (e.g. number of
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completed exercise sessions, type and intensity of exercise training), patient education (none to extensive self-management programmes)
andhowprogrammeswere organised (within one setting, e.g. pulmonary rehabilitation, to across several settings, e.g. hospital, outpatient
centre and home).
Key results: Quality of life and exercise capacity were improved by rehabilitation, and the effect was substantially larger than the
minimal important difference. Results for hospital readmissions and mortality were diverse, with some studies showing that pulmonary
rehabilitation reduced hospital admissions and mortality compared with usual community care (no rehabilitation), and other studies
not showing such effects.
Quality of the evidence: Uncertainty about reasons for differences across trials in terms of hospital readmissions and mortality led to
downgrading of the quality of evidence (moderate-quality evidence for reduction in hospital readmissions and low-quality evidence for
reduction in mortality). The quality of evidence was high for quality of life and exercise capacity.
Conclusion: Pulmonary rehabilitation improves quality of life and exercise capacity and is a safe intervention for patients with COPD
after they have experienced an exacerbation. The reasons for diverse effects on hospital readmissions and mortality, however, are not
fully clear. Future studies should explore whether the extent of the rehabilitation programme and the organisation of such programmes
within specific healthcare systems (e.g. within the rehabilitation setting vs embedded in the continuum of care from hospital to home
to outpatient care) determines the effects of rehabilitation after COPD exacerbations.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Pulmonary rehabilitation versus usual care for patients with COPD
Population: part icipants with COPD who had experienced a recent exacerbat ion
Setting: inpat ient, outpat ient or home-based
Intervention: rehabilitat ion
Comparison: usual care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with control Risk with rehabilitation
Hospital readmission
(to end of follow-up,
median 9 months)
High risk for 1-year readmission OR 0.44
(0.21 to 0.91)
810 (8 RCTs) ⊕⊕⊕©
Moderatea
500 per 1000 306 per 1000
(174 to 476)
Mortality (to end of
follow-up, median 12
months)
High risk for 1-year mortality OR 0.68
(0.28 to 1.67)
670
(6 RCTs)
⊕⊕©©
Lowa,b
None of the trials used
mortality as a primary
outcome, and none of
the trials was powered
to detect a meaningful
ef fect of rehabilitat ion
on mortality
150 per 1000 107 per 1000
(47 to 228)
Health-related quality
of lif e: St George’s Res-
piratory Quest ionnaire -
SGRQ: total score (to
end of follow-up, me-
dian 5 months)
SGRQ score at begin-
ning of rehabilitat ion
was typically around 65
Mean change f rom
baseline in SGRQ To-
tal score in the inter-
vent ion group was 7.80
units lower (95% CI -12.
12 to -3.47)
- 1003 (8 RCTs) ⊕⊕⊕⊕
Highc
A lower score indicates
better quality of lif e.
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Change f rom baseline
in 6-minute walking test
(to end of follow-up,
median 3 months)
6-Minute walking dis-
tance at beginning of
rehabilitat ion was typ-
ically around 300 me-
tres
Mean change f rom
baseline in 6-minute
walking test in the inter-
vent ion group was 62.
38 metres more (95%CI
38.45 to 86.31)
- 819 (13 RCTs) ⊕⊕⊕⊕
Highd
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: conf idence interval; OR: odds rat io; RR: risk rat io.
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of ef fect.
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of ef fect but may be substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded because of heterogeneity of treatment ef fects with unclear reasons.
bDowngraded because of large 95% CI crossing 1.0.
cStat ist ical test ing of heterogeneity showed signif icant dif f erences in results across trials, but we did not downgrade the
quality because the heterogeneity does not af fect interpretat ion of results. Studies did not have an act ive control, and
part icipants were aware of group assignment, but we did not downgrade because this did not lower our conf idence in the
est imate of ef fect.
dUnexplained substant ial stat ist ical heterogeneity detected (I2 = 87%), but we did not downgrade the quality because the
pooled ef fect is large and well above the minimal important dif f erence for the 6-minute walking test of 30 metres.
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B A C K G R O U N D
Clinical guidelines and documents of the American Thoracic
Society (ATS) and the European Respiratory Society (ERS) in-
clude positive recommendations for pulmonary rehabilitation af-
ter chronic obstructive pulmonary disease (COPD) exacerbations
based on earlier versions of this systematic review and its included
trials (BTS 2013; ERS ATS Statement 2013; GOLD 2016). How-
ever, recent studies indicate that post exacerbation rehabilitation
may not always be effective. In addition, concerns have arisen that
pulmonary rehabilitation may not be safe shortly after exacerba-
tions of COPD. Therefore, our aim is to update our previous
systematic review by assessing the effectiveness and safety of pul-
monary rehabilitation after exacerbations of COPD.
The protocol for this Cochrane review was based on a previously
published non-Cochrane systematic review (Puhan 2005).
Description of the condition
Exacerbations and hospitalisations in patients with COPD rep-
resent a major health burden for both patients and healthcare
systems in industrialised and developing countries (Chan-Yeung
2004; Kessler 2006; Seemungal 1998; Sin 2002; Sullivan 2000).
Acute exacerbations are the most common reason for hospi-
tal admissions and death among patients with COPD (Aaron
2014; Garcia-Aymerich 2003; Mannino 2002; Piquet 2013;
Soler-Cataluna 2005). In addition, patients with COPD have
reported reduced health-related quality of life (HRQL) (Kessler
2006; Schlenk 1998) compared with the healthy population,
which is further impaired by acute and repeated exacerbations
(Seemungal 1998). Patients are at risk of early death and contin-
ued exacerbations requiring hospitalisation (Aaron 2014; Piquet
2013; Soler-Cataluna 2005). Mortality rates during the year fol-
lowing a hospitalisation are around 35% (Almagro 2002; Connors
1996; Groenewegen 2003; Seneff 1995; Vitacca 2001), and rehos-
pitalisation rates are around 60% (Connors 1996; Cydulka 1997;
Escarrabill 2014; Groenewegen 2003; Martin 1982).
From the healthcare provider’s perspective, COPD is resource-
consuming (Ford 2015; Jansson 2013; Sullivan 2000). Acute ex-
acerbations are the cost drivers for COPD care, accounting for
more than 70% of COPD-related costs incurred as the result of
emergency visits and hospitalisations (NHLBI 2001; Oostenbrink
2004; Sullivan 2000).
Description of the intervention
Position papers of the American College of Physicians, the Ameri-
can College of Chest Physicians, the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) and the National Institute for
Health and Care Excellence (NICE) have provided recommen-
dations on acute care and follow-up management for acute ex-
acerbations (Amir 2011; GOLD 2016; NICE 2010). Pulmonary
rehabilitation could play an important role in peri-exacerbation
management (management around the time of an exacerbation)
because it combines several interventions that are known to im-
prove health status and prognosis, such as physical exercise, smok-
ing cessation, self-management education, optimisation of medi-
cations and psychological and social support (BTS 2013; ERSATS
Statement 2013; Maddocks 2015; Puhan 2014). A large body of
evidence on patients with stable COPD shows that pulmonary
rehabilitation improves exercise capacity and HRQL (McCarthy
2015), and that itmay be cost-effective (ERS ATSStatement 2013;
Griffiths 2001).
How the intervention might work
A multi-disciplinary approach to pulmonary rehabilitation ad-
dresses multiple risk factors for hospital readmission and determi-
nants of poor exercise capacity and quality of life. This combined
effect may accelerate recovery from exacerbations and lower the
risk of hospital readmission by improving exercise capacity, allevi-
ating symptoms and promoting better self-management.
Why it is important to do this review
COPD exacerbations are a major burden for patients, caregivers
and society. Evaluation of the effectiveness and safety of post ex-
acerbation strategies such as pulmonary rehabilitation could sub-
stantially lower the disease burden.
O B J E C T I V E S
To assess effects of pulmonary rehabilitation after COPD exacer-
bations on hospital admissions (primary outcome) and other pa-
tient-important outcomes (mortality, HRQL and exercise capac-
ity).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) comparing pulmonary reha-
bilitation with conventional community care after acute exacerba-
tions of COPD. We included studies reported as full text, those
published as abstract only and unpublished data.
6Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Types of participants
Participants with COPD after inpatient or outpatient care for
acute exacerbation. This review required that more than 90% of
study participants were patients with COPD.
Types of interventions
Any inpatient and/or outpatient pulmonary rehabilitation pro-
gramme, including at least physical exercise (endurance or strength
exercise, or both), delivered to patients who have received acute
care for an exacerbation of COPD. The rehabilitation programme
must commence immediately after initiation of exacerbation treat-
ment or within three weeks of initiation of exacerbation treatment.
We did not apply a criterion for the minimum number of exercise
sessions to be included in the review because guideline recom-
mendations provide no definition for when a programme quali-
fies as rehabilitation based on the number or type of exercise ses-
sions. Rehabilitation programmes could include additional com-
ponents such as self-management education, psychological sup-
port, dietary advice and breathing exercises. We excluded from
the review studies on pulmonary rehabilitation programmes that
included only neuromuscular stimulation or inspiratory muscle
training but no physical exercise programme. We included usual
care control groups.
Types of outcome measures
Primary outcomes
• Hospital admissions (at least one hospital admission during
follow-up)
Secondary outcomes
• HRQL as measured by generic (e.g. Short Form (SF)-36) or
disease-specific questionnaires (e.g. Chronic Respiratory
Questionnaire (CRQ), St George’s Respiratory Questionnaire
(SGRQ))
• Exacerbation rates (after discharge)
• Number of outpatient visits
• Length of readmissions
• Mortality
• Functional exercise capacity as measured by two-, three-,
four-, six- or 12-minute-walk test, or by a shuttle walk test
• Maximal exercise capacity
• Exercise endurance
• Withdrawals
• Adverse events
• Costs
Search methods for identification of studies
Electronic searches
We detailed in Appendix 1 search methods used in the previous
version of this review. The previously published version included
searches up to March 2010. The search period for this update is
March 2010 to October 2015.
For this update, we identified trials from the Cochrane Airways
Review Group Specialised Register (CAGR), which is maintained
by the InformationSpecialist for theGroup.ThisRegister contains
trial reports identified through systematic searches of bibliographic
databases including the Cochrane Central Register of Controlled
Trials (CENTRAL), MEDLINE, Embase, the Cumulative Index
toNursing andAlliedHealth Literature (CINAHL), theAllied and
Complementary Medicine Database (AMED) and PsycINFO,
and by handsearching of respiratory journals andmeeting abstracts
(see Appendix 2 for details). We searched all records in the CAGR
using the search strategy presented in Appendix 3.
We also conducted a search of
ClinicalTrials.gov (www.ClinicalTrials.gov) and theWorld Health
Organization (WHO) trials portal (www.who.int/ictrp/en/). We
searched all databases from their inception to October 2015, with
no restriction on language of publication. We screened the list of
papers on pulmonary rehabilitation that is prepared bimonthly by
the Rehabilitation and Chronic Care Group of the European Res-
piratory Society (ERS) and sent to its members (MP). We com-
pleted handsearching on 5 April 2016.
Searching other resources
We screened reference lists from included primary studies, review
articles and conference proceedings of the American Thoracic So-
ciety (ATS) and the European Respiratory Society (ERS) (ERS
ATS Statement 2013), and we contacted experts in the field to ask
about additional published and unpublished studies. We applied
no restrictions on the language of articles and completed hand-
searching on 5 April 2016.
Data collection and analysis
Selection of studies
Three review authors/contributors (MP, EGS,MS) independently
assessed the titles and abstracts of all identified citations. Review
authors recorded and then compared decisions (to order full-text
article or reject). We resolved disagreements by consensus with
close attention to the inclusion/exclusion criteria. Three review
authors/contributors (MP, EGS, MS) evaluated the full text of
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all potentially eligible papers and made a decision whether to in-
clude or exclude each study according to the inclusion and exclu-
sion criteria specified above. We again resolved disagreements by
consensus with close attention to the inclusion/exclusion criteria.
We excluded all studies that did not fulfil all of the criteria and
listed their bibliographic details, along with reasons for exclusion.
A third review author (CC or TT) resolved discrepancies if two
review authors disagreed.
Data extraction and management
Three independent review authors/contributors (MP, EGS, MS)
independently screened the full texts of included studies and
recorded details about study design, interventions, participants
and outcome measures in a predefined Windows Excel form. We
tested the data collection forms on a small sample of studies with
strong likelihood for inclusion and exclusion. A third review au-
thor resolved disagreements. We registered bibliographic details
such as study author, journal, year of publication and language.
Assessment of risk of bias in included studies
We assessed risk of bias in included studies as high, low or unclear
using the Cochrane ’Risk of bias’ tool (Higgins 2011) and the
following risk types.
• Random sequence generation.
• Allocation concealment.
• Blinding of participants and personnel.
• Blinding of outcome assessment.
• Incomplete outcome data.
• Selective outcome reporting.
• Other bias.
We recorded the initial degree of discordance between review au-
thors and corrected discordant scores based on obvious errors. We
resolved discordant scores based on real differences in interpreta-
tion through consensus or third party arbitration. Review authors
were not blinded to names of study authors, institutions or jour-
nals nor to trial outcomes.
Measures of treatment effect
When possible, estimates and confidence limits were related to
the minimal important difference (MID) (Schunemann 2005)
for each outcome. We assessed whether estimates and 95% con-
fidence limits for differences between study groups exceeded the
MID (Chronic Respiratory Questionnaire ± 0.5 on seven-point
scales and St George’s Respiratory Questionnaire ± 4 points;
Schunemann 2003) or represented an important effect (six-minute
walk distance ≥ 30 meters, which is based on a broad consensus
and is less than the previous definition, and incremental shuttle
walk test ≥ 47.5 meters; Holland 2014; Singh 2014).
Unit of analysis issues
The unit of analysis was the participant. We neither encountered
nor expected any non-standard study designs.
Dealing with missing data
We contacted study authors to obtain missing information.
Assessment of heterogeneity
We used forest plots to compare results across trials and the I2
statistic to measure heterogeneity among them. When we identi-
fied substantial heterogeneity, we reported this and explored possi-
ble causes by performing prespecified subgroup analyses (extent of
rehabilitation programme, length of follow-up (< 3 months vs≥ 3
months)) and by analysing methodological items derived from the
quality assessment (generation of random sequence, concealment
of random allocation and blinding (low risk vs unclear or high
risk). Previous versions of this review used length of follow-up
and methodological items (Puhan 2011). Compared with earlier
versions of this review, investigators created extent of rehabilita-
tion programmes as a new explanatory variable for heterogeneity
(see below) on the basis of recent discussions (Hopkinson 2014;
Maddocks 2015; Spruit 2014) and before meta-analyses were car-
ried out.
Pulmonary rehabilitation programmes can differ in many aspects,
which may influence their effectiveness. Such programmes take
place in inpatient, outpatient or home-based settings; are of short
(e.g. six weeks) or long (e.g. six months) duration and involve dif-
ferent intensity (e.g. training twice per week, daily training). Ex-
ercise training can include both endurance and strength training
or either of the two. and many types of exercise training can be
chosen to match the needs of patients. Pulmonary rehabilitation
programmes also differ in terms of patient education offered, from
basic advice to extensive self-management programmes. Finally,
adherence to a pulmonary rehabilitation programme determines
the amount of training and education actually received by partic-
ipants (e.g. attendance at 60% of planned exercise sessions).
Given the increasing diversity of pulmonary rehabilitation pro-
grammes and various ways to implement them in real-world prac-
tice, we introduced a new reason to explain heterogeneity as part
of the update of this systematic review. We assessed how exten-
sive rehabilitation programmes were as a possible source of het-
erogeneity of trial results, and we stratified meta-analyses by stud-
ies that offered an extensive pulmonary rehabilitation programme
and studies that offered only moderately, slightly or not exten-
sive pulmonary rehabilitation programmes (summarised as “less
extensive” rehabilitation programmes). Review authors developed
and used an approach not used before for assessment of the ex-
tent of rehabilitation programmes. When possible, we followed
the statements and guidelines of national (British Thoracic Soci-
ety; BTS 2013) and international societies (ERS and American
Thoracic Society (ATS); ERS ATS Statement 2013). We did not
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upgrade or downgrade the extent of rehabilitation programmes
if programme characteristics were in line with these statements
and guidelines, but we downgraded or upgraded, respectively, the
extent of programmes if some components were less than or ex-
ceeded what these guidance documents recommend. We consid-
ered pulmonary rehabilitation programmes to be extensive if:
• participants followed, on average, at least 16 exercise
training sessions, calculated as the total number of possible
exercise training sessions times the (average) attendance rate. For
example, if a programme was designed to include at least five
exercise training sessions in the hospital, followed by a standard
eight-week outpatient programme with three sessions per week,
5 + 24 = 29 sessions were possible. If the attendance rate was
80%, participants followed, on average, 23 exercise training
sessions. We selected a cut-off of 16 exercise sessions based on
duration of outpatient programmes of at least eight weeks, with
two to three sessions per week and an attendance rate of 80%
(thus 8*2.5 - 4 = 16 sessions), as recommended by ERS and ATS
(ERS ATS Statement 2013), rather than on the lower minimum
number of sessions (≥ 12) recommended by BTS (BTS 2013);
• they included two to three exercise training sessions per
week, as recommended by ERS, ATS and BTS (ERS ATS
Statement 2013, BTS 2013);
• exercise training included at least endurance exercise (±
strength exercise), as recommended by ERS, ATS and BTS (ERS
ATS Statement 2013, BTS 2013); or
• most exercise training sessions were supervised by
physiotherapists or other trained health professionals, as
recommended by ERS, ATS and BTS (ERS ATS Statement
2013, BTS 2013).
Similar to the GRADE approach, we downgraded the extent of
pulmonary rehabilitation programmes for the following reasons
(e.g. by -1 from extensive to moderately extensive).
• By -1 if the total number of exercise training sessions was
between 10 and 15, and by -2 if the total number of exercise
training sessions was less than 10.
• By -1 if fewer than 2 training sessions were provided per
week.
• By -1 if training was offered that is unlikely to modify the
risk for hospital admissions and mortality, and is unlikely to
improve health-related quality of life and exercise capacity (e.g.
only outdoor walking without the use of tests or parameters that
would ensure training of at least moderate intensity, only
strength exercise, less than 20 minutes of endurance training per
session, other reasons).
• By -1 if most exercise training sessions were not supervised
by physiotherapists or other trained health professionals, and by
-2 if most exercise training sessions (> 80%) were not supervised
at all.
We upgraded the extent of pulmonary rehabilitation programmes
for the following reasons.
• By +1 if the total number of exercise training sessions was
greater than 30.
• By +1 if pulmonary rehabilitation programmes included an
extensive self-management programme (i.e. patient education
about COPD, self-monitoring, early action when exacerbations
develop, written action plan, etc.).
Two review authors (EGS and MP) independently graded the
pulmonary rehabilitation programmes of all included trials and
resolved discrepancies in grading by discussion. If discrepancies
remained, a third review author made the final decision.
Finally, we assessed how results changed with the addition of new
studies and stratified analyses by studies included in the earlier
version of this review versus studies added in this update.
Assessment of reporting biases
When we were able to pool more than 10 studies, we created
and examined a funnel plot to explore possible small study and
publication biases.
Data synthesis
We pooled trial results by calculating mean differences (MDs) and
pooled odds ratios (ORs) using random-effects models in Review
Manager 5 (RevMan 2014).
’Summary of findings’ table
We included a ’Summary of findings’ table for the 2016 update
of the review. We selected the following outcomes in consultation
with the Cochrane Airways Review Group editorial team: hospital
readmissions, mortality, SGRQ total score and six-minute walk
test.
We used the five GRADE considerations (study limitations, con-
sistency of effect, imprecision, indirectness and publication bias)
to assess the quality of a body of evidence as it relates to studies that
contributed data to the meta-analyses for prespecified outcomes.
We used methods and recommendations described in Section 8.5
and Chapter 12 of the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011) along with GRADEpro software
(December 2015 version). We justified all decisions to downgrade
or upgrade the quality of studies by using footnotes and made
comments to aid the reader’s understanding of the review when
necessary.
Subgroup analysis and investigation of heterogeneity
We performed prespecified subgroup analyses when extent of the
rehabilitation programme (extensive vs less extensive), length of
follow-up (< 3 months vs≥ 3 months) and methodological items
from the quality assessment (generation of random sequence, con-
cealment of random allocation and blinding (low risk vs unclear
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or high risk) served as stratification variables (see Assessment of
heterogeneity for details).
We used the formal test for subgroup interactions provided in
Review Manager 5.3 (RevMan 2014).
Sensitivity analysis
We considered using a fixed-effect model for sensitivity analyses
but, given the heterogeneity of results across studies, we decided
to use only a random-effects model.
R E S U L T S
Description of studies
Results of the search
In the original search, we identified 1759 citations through
searches of electronic databases. We excluded 1740 citations after
screening titles and abstracts and retrieved a total of 22 studies
for detailed evaluation (19 obtained through searches of electronic
databases and three via handsearching). We included six reports
in the original review (Behnke 2000; Kirsten 1998; Man 2004;
Murphy 2005; Nava 1998; Troosters 2002).
The search for the first update covered the period from July 2008
toMarch 2010. We identified 62 references through the electronic
database search.We retrieved for full-text assessment three articles
from electronic databases and one via handsearching.We included
three additional references (Carr 2009; Eaton 2009; Seymour
2010) in the review update.
The search for the most recent and current update covered the
period fromApril 2010 toOctober 2015,with handsearches run to
5 April 2016. We identified 449 references through the electronic
database search.We retrieved for full-text assessment 20 references
from electronic databases and two via handsearching. Figure 1
shows a study flow diagram. We included 11 additional studies
(Borges 2014; Deepak 2014; Greening 2014; He 2015; Ko 2011;
Tang 2012; Torres-Sánchez 2014; Torres-Sánchez 2015; Troosters
2010; Ko 2016; Liao 2015) in this review update.
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Figure 1. Study flow diagram.
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Included studies
Twenty studies (drawn from 22 citations) met the eligibility crite-
ria of this review. Eighteen studies were published in peer-reviewed
journals, one study as an abstract (Torres-Sánchez 2014) and one
as an abstract and as part of a full publication (Troosters 2002). The
studies involved a total of 1477 participants whowere in the recov-
ery phase of a recent COPD exacerbation. In 12 studies (Behnke
2000; Borges 2014; Eaton2009;Greening2014;He2015;Kirsten
1998; Liao 2015; Nava 1998; Tang 2012; Torres-Sánchez 2014;
Torres-Sánchez 2015; Troosters 2010), participants started inpa-
tient pulmonary rehabilitation within two to eight days of hospi-
tal admission; in one study (Carr 2009), participants started an
inpatient or outpatient rehabilitation programme; in six studies
(Deepak 2014; Ko 2011; Ko 2016; Man 2004; Seymour 2010;
Troosters 2002), outpatient rehabilitation was initiated after in-
patient exacerbation treatment; and in one study (Murphy 2005),
outpatient rehabilitation was started after “home from hospital
care programme” for the exacerbation. Thirteen studies reported
rehabilitation programme completion rates ranging from 40% to
94% (median, 77%). Only one study (Troosters 2010) provided
details about the exacerbation treatment provided to participants
(i.e. 32 mg oral corticosteroids for one week). For eight studies,
we found that participants followed extensive pulmonary rehabil-
itation (Behnke 2000; Man 2004; Ko 2011; Ko 2016; He 2015;
Nava 1998; Seymour 2010; Troosters 2002), and in seven stud-
ies, they completed moderately extensive pulmonary rehabilita-
tion (Carr 2009; Eaton 2009; Greening 2014; Kirsten 1998; Liao
2015; Murphy 2005; Torres-Sánchez 2015), whereas participants
followed slightly extensive pulmonary rehabilitation in one study
(Tang 2012) and pulmonary rehabilitation that was not exten-
sive in two studies (Borges 2014; Troosters 2010). For two stud-
ies, we could not determine the extensiveness of the pulmonary
rehabilitation programme (Deepak 2014; Torres-Sánchez 2014).
See Assessment of heterogeneity and Characteristics of included
studies for details of the assessment of each included study (Table
1).
Excluded studies
Themain reason for study exclusion was that the study population
did not have COPD. We recorded reasons for exclusion of 10
studies in the Characteristics of excluded studies table.
Risk of bias in included studies
For details about risk of bias judgements and an overview of judge-
ments across studies, see the Characteristics of included studies
tables (Figure 2).
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Figure 2. Risk of bias summary: review authors’ judgments about each risk of bias item for each included
study.
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Allocation
When reported, available information regarding treatment group
assignment and allocation concealment indicated low risk of bias.
Blinding
Participants could not be blinded in these studies; this fact may
have introduced bias for outcomes such as health-related quality
of life, but it is less likely to be an important source of bias for
mortality and hospital readmission. Outcome assessors could be
blinded for outcomes such as exercise endurance or six-minute
walk distance, and three studies described such blinding (Borges
2014; Carr 2009; Greening 2014).
Incomplete outcome data
Some studies did not assess the outcomes of participants who
dropped out of rehabilitation programmes or were lost to follow-
up. However, reported study flows suggest that the extent of attri-
tion bias is likely to be small.
Selective reporting
We found no evidence of reporting bias.
Other potential sources of bias
We identified no other potential sources of bias. We did not create
a funnel plot for the primary outcome, as fewer than 10 studies
contributed to this outcome.
Effects of interventions
See: Summary of findings for the main comparison Pulmonary
rehabilitation versus usual care
Hospital readmissions
Eight studies involving 810 participants (Behnke 2000; Eaton
2009; Greening 2014; Ko 2011; Ko 2016; Man 2004; Murphy
2005; Seymour 2010) contributed data on hospital readmissions.
The follow-up period for these studies ranged from three to 18
months, with a median duration of nine months. Moderate-qual-
ity evidence (Summary of findings for the main comparison)
shows that pulmonary rehabilitation reduced hospital readmission
(pooled odds ratio (OR) 0.44, 95% confidence interval (CI) 0.21
to 0.91; Figure 3). However, the results were heterogenous (I2
= 77%), with four studies showing large and statistically signifi-
cant reductions in the risk of hospital admission associated with
pulmonary rehabilitation, and four studies showing no effect. Al-
though subgroup analyses performed to investigate heterogene-
ity showed no statistical significance (P < 0.05), extensiveness of
rehabilitation programmes and methodological quality may ex-
plain heterogeneity, and length of follow-upmay not (Analysis 1.7;
Analysis 1.8; Analysis 1.9; Analysis 1.10; Analysis 1.11). Figure
4 shows that studies newly included in this update reported, on
average, smaller effects of rehabilitation than were noted in earlier
studies.
Figure 3. Forest plot of comparison: 1 Rehabilitation versus control, outcome: 1.1 Hospital readmission (to
end of follow-up).
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Figure 4. Forest plot of comparison: 1 Rehabilitation versus control, outcome: 1.37 Hospital readmission
(to end of follow-up) with separated new trial data.
Mortality
Six studies including 670 participants contributed data onmortal-
ity (Behnke 2000; Greening 2014; Ko 2011; Ko 2016;Man 2004;
Troosters 2002). The follow-up period for these studies ranged
from three to 48 months, with a median duration of 12 months.
The quality of evidencewas low (Summary of findings for themain
comparison), and meta-analysis showed no statistically significant
effects of rehabilitation on mortality (pooled OR 0.68, 95% CI
0.28 to 1.67; Figure 5). Again, results were heterogenous (I2 =
59%), with one study showing reducedmortality, one study exces-
sive mortality and four no effect. Subgroup analyses showed statis-
tically significant differences in subgroup effects between studies
with more and less extensive rehabilitation programmes (Analysis
1.12) and between studies at low and high risk of bias (Analysis
1.14; Analysis 1.15), suggesting explanations for the heterogene-
ity, but length of follow-up did not explain heterogeneity (Analysis
1.13). As for hospital readmissions, Figure 6 shows that studies
newly included in this update reported, on average, smaller effects
of rehabilitation on mortality than were noted in earlier studies.
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Figure 5. Forest plot of comparison: 1 Rehabilitation versus control, outcome: 1.2 Mortality.
Figure 6. Forest plot of comparison: 1 Rehabilitation versus control, outcome: 1.38 Mortality with
separated new trial data.
Health-related quality of life
Two instruments were used to measure HRQL: The CRQ was
used in five studies involving 259 participants (Behnke 2000; Carr
2009; Eaton 2009; Man 2004; Seymour 2010), and the SGRQ
was used in eight studies involving 846 participants (Borges 2014;
Deepak 2014; Greening 2014; Ko 2011; Ko 2016; Man 2004;
Murphy 2005; Seymour 2010).
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High-quality evidence indicates that pulmonary rehabilitation
after an exacerbation improves health-related quality of life
(Summary of findings for the main comparison). The eight stud-
ies that used the SGRQ reported a statistically significant effect
on total score, which was above the MID of four points (mean
difference (MD) -7.80, 95% CI -12.12 to -3.47; Figure 7). Statis-
tically significant and important effects (greater than MID) were
also observed for the impact and activities domains of the SGRQ
and for the dyspnoea, fatigue and emotional function domains of
the CRQ (Analysis 1.3). Effects were not statistically significant
for SGRQ symptoms nor for CRQ mastery domains. Again, het-
erogeneity was evident in all of these analyses, but most studies
showed positive effects of pulmonary rehabilitation, with some
studies observing large effects and others smaller but statistically
significant effects. Extensive rehabilitation programmes showed
larger effects than less extensive rehabilitation programmes, but
differences between subgroups of trials (extensive vs less extensive
programmes) were not statistically significant for CRQ (Analysis
1.17) nor for SGRQ (Analysis 1.22). Subgroup analyses compar-
ing trials with respect to length of follow-up were inconsistent. Al-
though trials of short duration noted a smaller effect on the CRQ
(Analysis 1.18), investigators reported a larger effect on the SGRQ
(Analysis 1.23). Trials at high risk of bias with respect to conceal-
ment of random allocation showed statistically significantly larger
effects on the SGRQ (Analysis 1.25), but other subgroup analyses
revealed no statistically significant effects. Studies newly included
in this update showed, on average, smaller effects of rehabilitation
than were noted in earlier trials (Figure 8), but overall results did
not change to an important extent compared with the earlier ver-
sion of this review. One study involving 49 obese COPD partic-
ipants (Torres-Sánchez 2015) used the EuroQol 5D instrument
and found statistically significant effects of rehabilitation for the
domains of self-care, usual activities, anxiety and depression, and
for the visual analogue scale, but no effect for mobility and pain/
discomfort domains.
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Figure 7. Forest plot of comparison: 1 Rehabilitation versus control, outcome: 1.4 Health-related quality of
life: St George’s Respiratory Questionnaire.
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Figure 8. Forest plot of comparison: 1 Rehabilitation versus control, outcome: 1.39 Health-related quality
of life: SGRQ total with separated new trial data.
Exercise capacity
Thirteen studies involving 819 participants used the six-minute
walk test (Behnke 2000; Borges 2014; Carr 2009; Deepak 2014;
Eaton 2009; He 2015; Kirsten 1998; Ko 2011; Ko 2016; Liao
2015; Nava 1998; Troosters 2002; Troosters 2010), and four stud-
ies involving 448 participants used the shuttle walk test to mea-
sure exercise capacity (Greening 2014; Man 2004; Murphy 2005;
Seymour 2010). One study used the three-minute walk test (Tang
2012).
High-quality evidence (Summary of findings for the main
comparison) shows that six-minute walk distance (6MWD) im-
proved, on average, by 62 meters (95% CI 38 to 86; Figure 9) and
shuttle walk test distance by 48 meters (95% CI -1 to 97; Analysis
1.6); these findings were not statistically significant. Again, much
heterogeneity was evident, but most studies showed positive ef-
fects of pulmonary rehabilitation, and heterogeneity was driven
particularly by differences between studies showing very large ef-
fects and studies showing smaller but statistically significant effects.
Subgroup analysis comparing trials at low and high risk for bias
with respect to concealment of random allocation (Analysis 1.30)
showed statistically significantly smaller effects in trials at low risk
of bias. Studies at high risk of bias, because they lacked blinding,
showed statistically significantly larger effects on the shuttle walk
test (Analysis 1.36), but no other subgroup analyses revealed a rea-
son for heterogeneity (Analysis 1.27; Analysis 1.28; Analysis 1.29;
Analysis 1.31 for 6MWD; Analysis 1.32; Analysis 1.33; Analysis
1.34; Analysis 1.35 for shuttle walk test). Three-minute walk dis-
tance increased more in the low-intensity exercise group than in
the control group (effect size 0.4, 95% CI -0.5 to 1.3) or the high-
intensity exercise group (effect size 0.6, 95% CI -0.3 to 1.5), but
the differences were not statistically significant (Tang 2012). One
study involving 49 obese patients with COPD (Torres-Sánchez
2015) used the EuroQol 5D instrument and found statistically
significant effects of rehabilitation for the domains of self-care,
usual activities, anxiety and depression and for the two-minute
step-in-place test performed to assess exercise capacity, as well as
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a statistically significant effect of rehabilitation on the number of
repetitions performed (increase of 17.6 vs 4.9 repetitions, with 47
repetitions reported at baseline (both groups)).
Figure 9. Forest plot of comparison: 1 Rehabilitation versus control, outcome: 1.5 Change from baseline in
6-minute walking test.
Adverse events
Five studies involving 278 participants explicitly recorded adverse
events (Behnke 2000; Eaton 2009; He 2015; Man 2004; Tang
2012). Four studies reported no adverse events during rehabilita-
tion programmes. whereas one study (Tang 2012) reported one
serious event that occurred when a participant felt unwell, but
symptoms resolved within one hour and the participant continued
with the rehabilitation programme.
D I S C U S S I O N
Summary of main results
Overall evidence of high quality shows moderate to large effects
of rehabilitation on health-related quality of life and exercise ca-
pacity in participants with chronic obstructive pulmonary dis-
ease (COPD) that are well above the minimal important differ-
ence (MID) for theChronic Respiratory Questionnaire (CRQ), St
George’s Respiratory Questionnaire (SGRQ), the six-minute walk
distance test (6MWD) and the shuttle walk distance test (Holland
2014; Jones 2005; Schunemann 2003; Schunemann 2005; Singh
2014). Some recent studies showed no significant effect of reha-
bilitation on hospital readmissions and mortality. and introduced
heterogeneity as compared with the last update of this review. Such
heterogeneity of effects on hospital readmissions and mortality is
not fully understood at this point, which explains why review au-
thors assigned only moderate quality to evidence showing statisti-
cally significant effects of rehabilitation on hospital readmissions,
and low quality to evidence revealing its not statistically significant
effect on mortality.
Overall completeness and applicability of
evidence
The update of this systematic review was substantial in that review
authors included 11 additional studies, and this more than dou-
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bled the number of included study participants. Updated meta-
analyses that include a diverse set of trials informed the recent
debate about how pulmonary rehabilitation has to be delivered
to be beneficial for patients after acute exacerbations of COPD
(Maddocks 2015). This debate began because more recent tri-
als (Carr 2009; Eaton 2009; Greening 2014; Ko 2011) showed
smaller or no effects of pulmonary rehabilitation after acute ex-
acerbations of COPD compared with earlier versions of this sys-
tematic review (Puhan 2011). As we argued earlier (Puhan 2011),
small trials tend to overestimate the effect of an intervention com-
paredwith large trials (Cappelleri 1996; Ioannidis 1998; Kjaergard
2001; LeLorier 1997). This phenomenon may be attributed in
part to a publication bias, that is, the fact that small trials are more
likely to be published if they show statistically significant treat-
ment effects (Egger 1998). On the other hand, methodological
shortcomings of small trials such as inadequate generation of the
randomisation code, insufficient concealment of random alloca-
tion and lack of blinding may contribute to discrepancies between
the results of single large trials and pooled estimates based on small
trials (Kjaergard 2001). In our systematic review, included trials
had methodological limitations, and some subgroup analyses re-
vealed that risk of bias explains some of the heterogeneity noted for
different outcomes. Hence, it cannot be excluded that estimates
provided by the meta-analyses may represent overestimations of
the effect of pulmonary rehabilitation after an acute exacerbation.
Indeed, the largest trial, which included 320 participants, showed
no benefit of pulmonary rehabilitation (Greening 2014). How-
ever, this trial has been criticized for not offering an extensive
pulmonary rehabilitation programme (Hopkinson 2014; Spruit
2014). Participants in the intervention group followed, on aver-
age, 2.6 supervised sessions during hospital admission, then re-
ceived largely unsupervised training after discharge. Some may ar-
gue that we should not have included this trial in this systematic
review because the intervention was not designed or implemented
as a rehabilitation programme that is extensive enough to have an
effect on hospital readmissions, mortality and other outcomes. It
is difficult to draw a line to show when a programme qualifies as a
pulmonary rehabilitation programme in accordance with interna-
tional standards (ERS ATS Statement 2013), so we decided to use
rather inclusive trial eligibility criteria. Such an approach offers
the opportunity to explore reasons for heterogeneity across trials,
which may be highly informative for practice. For this purpose,
we applied a scoring approach to assess the extensiveness of a pul-
monary rehabilitation programme (using addition and subtrac-
tion of points in a way that is similar to the GRADE approach).
When developing this approach, we recognised that multiple cri-
teria should be used rather than a single criterion, such as the
number of completed training sessions or the combination of en-
durance and strength exercise. A single criterion is not sufficient
for evaluation of complex interventions such as pulmonary reha-
bilitation, wherein multiple components act synergistically and
introduce the risk of mis-classifying studies. Therefore, we consid-
ered the number of exercise training sessions, the frequency of ex-
ercise training and type and supervision of training, as well as self-
management education, in assessing how extensive pulmonary re-
habilitation programmes were (Assessment of heterogeneity). As
much as possible, we aligned the cut-offs for upgrading and down-
grading the extensiveness of rehabilitation programmes with the
recent European Respiratory Society (ERS)-American Thoracic
Society (ATS) statement (ERS ATS Statement 2013) and British
Thoracic Society (BTS) guidelines on pulmonary rehabilitation
(BTS 2013). Although two independent review authors assessed
programmes and sought consensus, we cannot exclude that oth-
ers may classify some programmes differently. However, Table 1
presents all reasons for downgrading or upgrading of evidence for
each study.
Results of this systematic review suggest that it may matter how
pulmonary rehabilitation is delivered. The eight trials that offered
and implemented an extensive programme showed mostly large
and consistent effects on readmissions, health-related quality of
life and exercise capacity while also suggesting an effect on mor-
tality. Although the programmes of these eight trials differed (see
Characteristics of included studies and Table 1), all offered many
training sessions (Behnke 2000; Nava 1998; Troosters 2002) or
programmes long in duration (Behnke 2000; Troosters 2002), or
they added extensive self-management education to the exercise
programme (Ko 2016; Man 2004; Seymour 2010). The results of
less extensive programmes are also important because some reflect
barriers for implementation and uptake of pulmonary rehabili-
tation after acute exacerbations of COPD. For example, today’s
hospital admission for a COPD exacerbation is often too short in
duration to permit initiation of a programme. Also, patients who
are admitted are often old and have multiple conditions, which
may render the uptake of pulmonary rehabilitation difficult. The
transition from the inpatient to the outpatient setting and the
organisation required along the continuum of care are challeng-
ing, and patients may not continue with rehabilitation or may
not start at all. In some countries, reimbursement schemes do not
allow for extensive rehabilitation programmes. All of these chal-
lenges have been recently summarised and discussed (ERS ATS
Statement 2013).
The applicability of current evidence also requires consideration
that the group of patients willing or motivated by their healthcare
professionals to participate in rehabilitation is probably quite a se-
lect one. This does not preclude that patients with COPD in gen-
eral would benefit from rehabilitation after an exacerbation, but
one should be cautious in judging the applicability of the results
of this systematic review and should consider local circumstances
and barriers. Conducting trials on pulmonary rehabilitation after
an exacerbation is challenging. First, recruitment of participants is
difficult because many may not wish to be randomly allocated to
different types of post exacerbation management in a situation of
poor health status (Benzo 2015). One trial on pulmonary rehabili-
tation after an exacerbation was stopped because only a few partic-
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ipants could be recruited (Van den Berg 2015). Recruitment was
very slow in one trial comparing rehabilitation after exacerbation
with rehabilitation in a stable pulmonary state (Puhan 2012), and
another trial had to be stopped before the recruitment target was
reached (Spaar 2009). Second, individuals willing to participate in
a trial are likely to have a preference for pulmonary rehabilitation.
If they are randomised to the control group or to rehabilitation
after a period of time, theymight ask for pulmonary rehabilitation
at any time during follow-up. Given the clear benefits of this in-
tervention for patients in a stable condition as confirmed in meta-
analyses (McCarthy 2015), patients who experience an exacerba-
tion can hardly be refused access to rehabilitative strategies. What-
ever design investigators choose, a careful discussion of ethical and
methodological issues is necessary before large trials are under way.
Quality of the evidence
The quality of the evidence was moderate for hospital readmis-
sions, low for mortality and high for health-related quality of life
and exercise capacity. The main reason for downgrading the qual-
ity of evidence for hospital readmissions and mortality is the het-
erogeneity of results, with some trials showing positive effects of
rehabilitation, some no effects and one even revealing a negative
impact of rehabilitation on mortality (Greening 2014). In addi-
tion, none of the trials included mortality as a primary outcome,
and most reported durations of follow-up that were too short for
an effect of pulmonary rehabilitation on mortality to be detected.
Reasons for downgrading or upgrading the quality of evidence are
given in Summary of findings for the main comparison.
Potential biases in the review process
Strengths of this systematic review include the extensive literature
search, rigorous adherence to a predefined protocol and successful
contact with authors of the included studies, all of whom provided
additional information about their data.
We split the studies into subgroups before we reviewed the results,
but we defined the extensiveness of rehabilitation programmes in
a somewhat arbitrary way.
Agreements and disagreements with other
studies or reviews
Compared with pulmonary rehabilitation in patients with COPD
in stable condition, the effect size of rehabilitation on health-re-
lated quality of life is similar among patients who have recently
had an exacerbation of COPD.Mean differences between rehabil-
itation and control groups for CRQ dyspnoea, fatigue, emotional
function and mastery domains in this Cochrane review were close
to those observed in the Cochrane review on pulmonary rehabili-
tation for people with stable COPD (McCarthy 2015). Compared
with the earlier version of this Cochrane review (Puhan 2011), the
current evidence base is more diverse because different pulmonary
rehabilitation programmes have been tested across a wide range of
participants and settings around the world. Also, effect estimates
became smaller with the addition of new trials (Figure 4; Figure
6; Figure 8; Figure 10)
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Figure 10. Forest plot of comparison: 1 Rehabilitation versus control, outcome: 1.40 Change from baseline
in 6-minute walking test with separated new trial data.
When only trials with an extensive rehabilitation programme were
considered (Behnke 2000; He 2015; Ko 2011; Ko 2016; Man
2004; Nava 1998; Seymour 2010; Troosters 2002), the effects
were larger than those seen in stable patients. Together with large
improvements in exercise capacity and, in particular, substan-
tial risk reduction for hospital admissions, pulmonary rehabilita-
tion appears to be a particularly attractive addition to the treat-
ment of patients after an exacerbation if an extensive rehabilita-
tion programme can be implemented. Several possible explana-
tions have been proposed for these large effects. First, as men-
tioned above, exacerbations lead to significant reductions in mus-
cle function (Spruit 2003) and physical activity (Pitta 2006). This
initial deterioration may render patients more likely to improve
following pulmonary rehabilitation. Pulmonary rehabilitation is
a particularly potent intervention for reverting physical inactiv-
ity (Troosters 2010a), and it has been shown that patients whose
physical activity levels improve have less chance of being readmit-
ted (Garcia-Aymerich 2006; Pitta 2006). Second, because eligible
participants had been hospitalised for a COPD exacerbation, a de-
ficiency in self-management or education may be evident among
this group. This deficiency may be targeted in part by the reha-
bilitation intervention, and patient education may be of partic-
ular benefit for modifying behaviour in these patients. Indeed, a
major study of a patient management programme that included
home exercise for patients with COPD after an acute exacerbation
reported impressive results (Bourbeau 2003). In this study, the
mean number of hospital admissions per participant was reduced
from 1.6 to 0.9 during the year following hospital admission for
an acute exacerbation. It is well known from earlier studies that the
recovery period is long, even for patients who have no further ex-
acerbations, and that another exacerbation within six months can
markedly limit recovery (Spencer 2003). A final explanation for
the attractiveness of pulmonary rehabilitation programmes may
be the effect of pulmonary rehabilitation on depressive symptoms
after exacerbations. Depression is a significant risk factor for read-
mission, and pulmonary rehabilitation has been shown to improve
depressive symptoms among depressed patients (Coventry 2007;
Trappenburg 2005). Our meta-analyses show that pulmonary re-
habilitation during the recovery period is superior to usual care in
terms of prognosis and health-related quality of life.
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Do we need more trials on pulmonary rehabilitation
after COPD exacerbations?
A large body of available evidence from the systematic review
on stable patients with COPD and from this systematic review
shows large effects of pulmonary rehabilitation among patients
with COPD (McCarthy 2015). Recently available trial findings
show that many different exercise protocols are feasible and effec-
tive for patients with COPD, even if patients have poor health
status, as is often the case during and after rehabilitation (ERS
ATS Statement 2013). Exercise modalities include various forms
of endurance and strength training, specific resistance training
during hospital admission (Troosters 2010a), neuromuscular elec-
trical stimulation and interval training, among others (ERS ATS
Statement 2013; Sillen 2009).
Questions now may be focused less on the effectiveness of pul-
monary rehabilitation after a COPD exacerbation in principle
and more on how rehabilitation programmes should be designed
and implemented, and how practitioners can foster patient uptake
(ATS ERS Policy statement 2015). Uptake of pulmonary rehabili-
tation by patients is often low. In the Eaton trial, for example, 97 of
288 participants agreed to enrol in the trial; 47 were randomised to
pulmonary rehabilitation, but only 19 of these 47 participants ad-
hered to the rehabilitation programme (Eaton 2009). Those who
adhered to the programme had substantially lower risk of readmis-
sion thanparticipantswhodidnot adhere to the rehabilitationpro-
gramme, which corroborates the results of this Cochrane review
showing that extensive rehabilitation programmes may be effec-
tive. Researchers should explore new ways of motivating patients
to participate in pulmonary rehabilitation. For example, practi-
tioners can explore the preferences of patients in terms of setting
and type of exercise training, so the programme can be individu-
alised according to both medical criteria and patient preferences.
Also, the best timing for rehabilitation remains uncertain. Should
rehabilitation start during an admission or shortly thereafter, or
should it start when a patient’s condition is stable again? An advan-
tage of immediate rehabilitation after exacerbation is that it may
provide a window of opportunity for patient education because
patients may be more willing to change their health behaviour af-
ter an exacerbation. Also, continuity of care is possible if patients
are immediately referred to pulmonary rehabilitation. A disadvan-
tage of rehabilitation after exacerbation is that patients often re-
exacerbate within weeks, so that the rehabilitation process is inter-
rupted or even discontinued. Also, initiation of physical exercise is
challenging for patients after an exacerbation, and more time may
be needed to find the appropriate exercise protocol for an individ-
ual patient (Puhan 2005a). One trial addressed the comparison of
early versus late rehabilitation after an exacerbation but failed to
recruit enough participants (Puhan 2012).
The studies included in this Cochrane reviewhad amedian follow-
up of three months. Given that physical exercise and self-manage-
ment should be based on a long-term perspective, it is important
for researchers to gather more data on health outcomes and costs
over longer periods. Large and long-term randomised trials would
be ideal for addressing these important questions, but they may
not be feasible because of lack of funding, slow participant recruit-
ment and other reasons, as explained above. Therefore, advanced
observational study methods and analyses may be employed. Fi-
nally, more evidence on the cost-effectiveness of pulmonary re-
habilitation in the post exacerbation setting is needed to inform
policy decisions about pulmonary rehabilitation.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Evidence of moderate quality (on average) from 20 studies (1477
participants) suggests that pulmonary rehabilitation is an effec-
tive intervention for post exacerbation treatment of patients with
COPD. Effects leading to improved health-related quality of life
and exercise capacity are large. Effects on hospital readmission
were statistically significant in the meta-analysis but heterogenous
across trials, and investigators need to explore whether the exten-
siveness of rehabilitation programmes explains such heterogeneity.
Implications for research
The decision to begin new trials of pulmonary rehabilitation
should be made against the background of perceived ethics about
the benefit of pulmonary rehabilitation after exacerbation and
against the methodological and logistical challenges of such trials
if comparisons include a no-exercise intervention. Studies should
investigate how care providers can design and implement exten-
sive rehabilitation programmes with a long-term perspective that
are feasible, reimbursable and attractive enough for patients and
healthcare providers. Trials should assess the best timing of pul-
monary rehabilitation. Finally, formal cost-effectiveness analyses
should be conducted to estimate the financial benefit derived from
rehabilitation after COPD exacerbations.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Behnke 2000
Methods Randomised parallel-group trial
Participants 26 participants with COPD (mean age 67 years, 77%males,mean FEV1 36% predicted)
after inpatient treatment for acute exacerbation
Interventions Rehabilitation:within 4-7days after admission, inpatient pulmonary rehabilitationwith
endurance exercise (5walking sessions/d for 10 days), followed by 6months of supervised
home-based endurance exercise (3 walking sessions/d for 6 months). Completion rate
of pulmonary rehabilitation: 65.2% (15/23 participants)
Usual care: standard inpatient care without exercise and standard community care with
respirologist. Follow-up: 76 weeks
Outcomes CRQ, 6MWD, hospital readmission, mortality
Notes Pulmonary rehabilitation programme was considered extensive (upgraded by +1 for >
30 exercise sessions and downgraded by -1 for unsupervised training)
Financial support was provided by the Verein zur FoÈ rderung der Rehabilitations-
forschung in Schleswig-Holstein e.V., Deutsche Gesellschaft fuer Medizinische Rehabil-
itation and Landesversicherungsanstalt Freie und Hansestadt, Hamburg, Germany
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised; other information not
available
Allocation concealment (selection bias) Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not available from trial report.Outcome
may be affected by knowledge of treatment group
assignment
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Although unavoidable by definition, lack of blinding
may affect outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Unclear risk Information not provided in trial report. Potential
lack of blinding likely to affect outcome assessment
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Behnke 2000 (Continued)
Walk test
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups
Selective reporting (reporting bias) Low risk Outcome reporting is sufficiently complete and trans-
parent. Study authors provided individual participant
data. Clinical trial registration number not reported
Other bias Low risk No indication of other biases
Borges 2014
Methods Randomised parallel-group trial
Participants 29 participants with COPD (CG: n = 14, mean age 68 years, 71% males, mean FEV1
39% predicted; IG: n = 15, mean age 64 years, 53% male, mean FEV1 42% predicted)
admitted to the hospital for treatment of COPD exacerbation
Interventions Rehabilitation: exercise training started on third day of hospitalisation, inpatient pul-
monary rehabilitation (completed 5.6 sessions on average) with whole-body resistance
training for upper and lower limbs (session every morning with free weights in 2 sets of
8 repetitions). Completion rate of pulmonary rehabilitation: 95%. Follow-up: 1 month
Usual care: Participants received normative daily care, including chest physiotherapy,
non-invasive ventilation if needed and verbal instructions to carry on with their nor-
mative daily physical activities. Participants did not receive an exercise programme or a
recommendation to exercise after hospital discharge. Follow-up: 1 month
Outcomes SGRQ, 6MWD
Notes Pulmonary rehabilitation programme was considered not extensive (downgraded by -2
for < 10 exercise training sessions and by -1 for strength training only)
Financial support was provided by the Sao Paulo Research Foundation (Grant no. 2007/
51-354-7) and the Brazilian Scientific Foundation (Grant no. 305987/2010-0)
Clinical trial identifier: NCT01786928
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
Allocation concealment (selection bias) Low risk “Allocation was concealed in sequentially numbered,
sealed, opaque envelopes”
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Borges 2014 (Continued)
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Information not available from trial report. Although
unavoidable by definition, lack of blindingmay affect
outcome
Blinding (performance bias and detection
bias)
Mortality
Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Walk test
Low risk “Evaluation[s] were performed by a blinded evalua-
tor.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups
Selective reporting (reporting bias) Low risk Outcome reporting is sufficiently complete and trans-
parent. Clinical trial registration number is not re-
ported
Other bias Low risk No indication of other biases
Carr 2009
Methods Randomised parallel-group trial
Participants 34 participants with COPD (mean age 68 years, 44% males, mean FEV1 0.91 L) after
inpatient treatment for acute exacerbation
Interventions Rehabilitation: inpatient or outpatient pulmonary rehabilitation (based on participant
preference or location of initial PR) (2 hours/session over 3 weeks, completed between
9 and 15 sessions) with breathing exercise, strength and interval training and corridor
and treadmill walking or cycling; patient education (energy conservation, lung health,
drugs and stress management). Completion rate of pulmonary rehabilitation: 94% (16/
17 participants). Follow-up: 12 weeks
Usual care: standard inpatient and community care without exercise (not further spec-
ified). Follow-up: 12 weeks
Outcomes CRQ (primary outcome), 6MWD (secondary outcome)
Notes Pulmonary rehabilitation programmewas consideredmoderately extensive (downgraded
by -1 for 10-15 exercise training sessions)
Financial support provided by the Ontario Thoracic Society
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Carr 2009 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised; additional information not
available from trial report
Allocation concealment (selection bias) Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Although unavoidable by definition, lack of blinding
may affect outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
Low risk “The investigator responsible for collecting outcome
measures was unaware of group allocation.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups
Selective reporting (reporting bias) Unclear risk Outcome reporting is sufficiently complete and trans-
parent: Results for all listed primary and secondary
outcomes are reported. Clinical trial registration
number not reported
Other bias Low risk No indication of other biases
Deepak 2014
Methods Randomised parallel-group trial
Participants 60 participants with COPD (CG: mean age 58 years, 93% males, FEV1 53% predicted;
IG: mean age 59 years, 93% male, FEV1 47% predicted) after admission for treatment
of an acute exacerbation
Interventions Rehabilitation: within 2 weeks after discharge, supervised outpatient pulmonary re-
habilitation with limb strengthening and aerobic activities, education, nutrition and
psychosocial rehabilitation for 12 weeks, including chest physiotherapy for drainage of
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Deepak 2014 (Continued)
secretions, breathing retraining techniques, techniques to control dyspnoea. Adherence
to pulmonary rehabilitation not reported. Follow-up: 3 months
Usual care: conventional treatment. Follow-up: 3 months
Outcomes SGRQ, 6MWD
Notes Extensiveness of pulmonary rehabilitation programme could not be assessed
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described by study authors as follows: “randomisa-
tion was done by block randomisation technique”;
other information not available
Allocation concealment (selection bias) Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Information not available from trial report. Although
unavoidable by definition, lack of blindingmay affect
outcome
Blinding (performance bias and detection
bias)
Mortality
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Walk test
Unclear risk Information not provided in trial report. Potential
lack of blinding likely to affect outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
High risk Withdrawal and drop-out rates are not reported.
Selective reporting (reporting bias) Unclear risk Outcome reporting is sufficiently complete and trans-
parent: Results for all listed outcomes are reported.
Clinical trial registration number not reported
Other bias Low risk No indication of other biases
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Eaton 2009
Methods Randomised parallel-group trial
Participants 97 participants with COPD (mean age 70 years, 44%males,mean FEV1 36% predicted)
Interventions Rehabilitation: The patient started inpatient programme as soon as medically appro-
priate, as determined by the attending medical team. Inpatient programme: supervised
walking and upper/lower limb-strengthening exercise at least 30 minutes/d until dis-
charge, followed by outpatient programme: supervised exercise for 8 weeks (1-hour ses-
sion, twice weekly) and patient education (coping with dyspnoea, the importance of a
regular daily home exercise programme, management of activities of daily living, drugs,
vaccines, airway clearance techniques, nutritional advice, self-management and action
plans for exacerbations, stress and panic management, relaxation techniques, mood dis-
turbance, adapting to a chronic illness and end-of-life care). Only 19 (40%) patients
assigned to early rehabilitation satisfied the a priori definition of adherence (attendance
at 75% of rehabilitation sessions)
Follow-up: 12 weeks
Usual care: standardised care in accordance with ATS/ERS COPD guidelines and stan-
dardised advice on exercise and maintaining daily activities, but not further specified.
Follow-up: 12 weeks
Outcomes Hospital readmission and hospital days (primary outcomes); 6MWD, CRQ (secondary
outcomes)
Notes Pulmonary rehabilitation programmewas consideredmoderately extensive (downgraded
by -2 for < 10 exercise training sessions but upgraded by +1 for extensive self-management
training)
Financial support provided by the Green Lane Research and Educational Foundation
Clinical trial identifier: ACTRNO12605000372684
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
Allocation concealment (selection bias) Low risk Only information from computer available at time
of randomisation
Blinding (performance bias and detection
bias)
Hospital admission
High risk Outcomemay be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Although unavoidable by definition, lack of blinding
may affect outcome
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Eaton 2009 (Continued)
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
High risk Lack of blinding likely to affect outcome assessment.
“The nature of intervention precluded blinding of
participants and health care providers.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups
Selective reporting (reporting bias) Low risk Outcome reporting is sufficiently complete and trans-
parent. Clinical trial registration number reported
ACTRNO12605000372684
Other bias Low risk No indication of other biases
Greening 2014
Methods Randomised parallel-group trial
Participants 389 participants (CG: n = 193, mean age 71 years, 44% males, mean FEV1 57% pre-
dicted; IG: n = 196, mean age 71 years, 45% males, mean FEV1 52% predicted) admit-
ted to hospital for an exacerbation of chronic respiratory disease (320 (82%) patients
with COPD; CG: n = 151; IG: n = 169)
Interventions Rehabilitation: within 48 hours of hospital admission, supervised volitional (strength
and aerobic training) and non-volitional (neuromuscular electrical stimulation) tech-
niques (median duration of hospital admission 5 days). The mean number of sessions
during the hospital admission was 2.7 (SD 2.6) for aerobic training, 2.5 (SD 1.9) for
resistance training and 3.6 (SD 3.2) for neuromuscular electrical stimulation training. In
addition, a self-management and educational package was offered. Completion rate of
pulmonary rehabilitation: 86% for inpatient aerobic training, 90% for strength training
and 90% for neuromuscular electrical stimulation training
After discharge, participants received instructions on how to follow a progressive walk-
ing-based home exercise programme, to continue daily neuromuscular electrical stimu-
lation and to follow the self-management programme. The postdischarge training was
supported by telephone consultations from the pulmonary rehabilitation intervention
team, using motivational interviewing techniques, at 48 hours, 2 weeks and 4 weeks.
Continued daily adherence to the home programmewas reported by 54% of participants
for aerobic training and by 61% for resistance training. Follow-up: 12 months
Usual care: standard care during hospital admission (median duration of hospital ad-
mission 5 days) including airway clearance techniques, mobility and advice on smok-
ing cessation, dietetic advice and nutritional support if appropriate. No supervised or
progressive exercise programme was provided during the admission or immediately af-
ter discharge, but outpatient pulmonary rehabilitation was offered to all participants 3
months after discharge. Follow-up: 12 months
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Greening 2014 (Continued)
Outcomes Hospital readmissions, mortality (primary outcomes); SGRQ, ISWT and ESWT (sec-
ondary outcomes)
Notes Pulmonary rehabilitation programmewas consideredmoderately extensive (downgraded
by -2 formostly unsupervised training and upgradedby +1 for extensive self-management
training)
Financial support provided by the National Institute for Health Research (NIHR)
Collaboration for Leadership in Applied Health Research and Care in Leicestershire,
Northamptonshire and Rutland (CLAHRC LNR), by the NIHR Leicester Respiratory
Biomedical Research Unit and CLAHRC East Midlands, and by the University of Le-
icester Clinical Trials Unit
Clinical trial identifier: ISRCTN05557928
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Automated Internet-based service (www.sealedenve-
lope.com)
Allocation concealment (selection bias) Low risk No details but can be assumed because of use of auto-
mated Internet-based service (www.sealedenvelope.
com)
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Hospital admissions were captured through hospi-
tal databases and general practice records. Unclear if
group assignment was known while hospital admis-
sions were ascertained
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Although unavoidable by definition, lack of blinding
may affect outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
Low risk “All investigators performing the outcome measures
were blinded to treatment allocation.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups
“We used an intention to treat analysis to assess the
primary outcome.”
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Greening 2014 (Continued)
Selective reporting (reporting bias) Low risk Information is reported in a sufficiently complete and
transparent way. Clinical trial registration number re-
ported
Other bias Low risk Supplemental details of methods and analysis re-
ported
He 2015
Methods Randomised parallel-group trial
Participants 94 participants (CG: n = 28, mean age 74 years, 82%males, mean FEV1 39% predicted;
IG: n = 66, mean age 69 years, 91% males, mean FEV1 38% predicted) admitted to
hospital for an exacerbation of chronic respiratory disease. 101 enrolled; 7 withdrew after
randomisation (not included in analyses)
Interventions Rehabilitation: from the second day of hospital admission, exercise training (endurance
+ strength, twice daily), relaxation and breathing retraining and education. The mean
number of days of pulmonary rehabilitation was 9.1, which results in an average of 18
exercise sessions. Completion rate of pulmonary rehabilitation: not explicitly reported.
Follow-up: in-hospital period (average, 9 days)
Usual care: standard care during hospital admission (median duration of hospital ad-
mission, 10 days). Follow-up: in-hospital period (average, 10 days)
Outcomes 6MWD, CRQ, SGRQ, adverse events
Notes Pulmonary rehabilitation programme was considered extensive.
Financial support provided by grants from National Natural Science Foundation of
China (81200044) and Shanghai Pujiang Program (12PJ1407800) and Research Fund
for the Doctoral Program of Higher Education of China (20120072120070)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Information not available from trial report. Informa-
tion requested of study authors: “method of random
allocation by using a computer random number gen-
erator”
Allocation concealment (selection bias) Low risk Information not available from trial report. Informa-
tion requested of study authors: “randomisation pro-
cess was concealed from those responsible for recruit-
ing patients using central telephone randomisation
system”
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He 2015 (Continued)
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Health-related quality of life
Unclear risk Although unavoidable by definition, lack of blinding
may affect outcome
Blinding (performance bias and detection
bias)
Mortality
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Walk test
Unclear risk Information not available from trial report. Although
unavoidable by definition, lack of blindingmay affect
outcome
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up are not specified. Final number
of participants is not balanced between comparison
groups (intervention group, n = 66; control group. n
= 28)
Selective reporting (reporting bias) High risk CRQ domain scores not reported. Clinical trial reg-
istration number not reported
Other bias Low risk No indication of other biases
Kirsten 1998
Methods Randomised parallel-group trial
Participants 29 participants with COPD (mean age 64 years, 90%males,mean FEV1 36% predicted)
after inpatient treatment for acute exacerbation
Interventions Rehabilitation: within 6 to 8 days after admission, inpatient pulmonary rehabilitation
with endurance exercise (5walking sessions/d for 10days). Completion rate of pulmonary
rehabilitation: not reported
Usual care: standard inpatient care without exercise (not further specified). Follow-up:
11 days
Outcomes 6MWD
Notes Pulmonary rehabilitation programmewas consideredmoderately extensive (downgraded
by -1 for partly unsupervised training)
Financial support provided by the Landesversicherungsanstalt (LVA) Freie und Hanses-
tadt Hamburg
Risk of bias
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Kirsten 1998 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised; additional information not
available from trial report
Allocation concealment (selection bias) Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Information not available from trial report. Although
unavoidable by definition, lack of blindingmay affect
outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
Unclear risk Information not provided in trial report. Potential
lack of blinding likely to affect outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Losses to follow-up are not specified, although the fi-
nal number of participants is balanced between com-
parison groups
Selective reporting (reporting bias) Unclear risk Outcome reporting is sufficiently complete and trans-
parent. Clinical trial registration number not re-
ported
Other bias Unclear risk Unclear further potential bias
Ko 2011
Methods Randomised parallel-group trial
Participants 60 participants with COPD (CG: n = 30, mean age 74 years, 1 female, mean FEV1 41%
predicted; IG: n = 30, mean age 73 years, 100% males, FEV1 46% predicted) admitted
with COPD exacerbation
Interventions Rehabilitation: outpatient pulmonary rehabilitation (within 2-3 weeks after discharge)
with endurance training for 8 weeks (3 sessions/wk, 2 hours each session), advice to
perform home exercises for at least 20 minutes/d and education on breathing techniques
and how to cope with daily activities. Completion rate of pulmonary rehabilitation: 73%
(22/30). Follow-up: 12 months
Usual care: instructions to have regular exercise. Follow-up: 12 months
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Ko 2011 (Continued)
Outcomes SGRQ, 6MWD, hospital readmissions, emergency admissions, mortality
Notes Pulmonary rehabilitation programme was considered extensive.
Only a small proportion of participants received long-acting bronchodilators, whichmay
have limited their ability to exercise
Financial support provided by the Hong Kong Lung Foundation Grant and the Respi-
ratory Research Fund of the Chinese University of Hong Kong
Clinical trial identifier: NCT00287625
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A computer programme (allocation by minimiza-
tion) was used to assist the randomisation of subjects
equally into each group taking into account five fac-
tors; age (< 70 or ≥ 70 years), gender, length of hos-
pital admission (< 7 or≥ 7 days), 6 min walk (6MW)
test (< 100 or ≥ 100 m) and predicted FEV1 (< 30
or ≥ 30%).”
Allocation concealment (selection bias) Low risk Used minimisation when allocation was concealed
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Information not available from trial report. Although
unavoidable by definition, lack of blindingmay affect
outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
High risk Information not available from trial report. Although
unavoidable by definition, lack of blindingmay affect
outcome
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups
“We used intention-to-treat analyses for all subjects
who had been randomised.”
Selective reporting (reporting bias) Low risk Information is reported sufficiently complete and in
a transparent way. Clinical trial number reported
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Ko 2011 (Continued)
Other bias Unclear risk Unclear further potential bias
Ko 2016
Methods Randomised parallel-group trial
Participants 180 participants with COPD (mean age 75 years, 96% males, mean FEV1 45% pre-
dicted) admitted for COPD exacerbation
Interventions Rehabilitation: comprehensive programmewithmulti-disciplinary approach at discharge
from hospital, which included respiratory nurse education, exercise training programme
at home or a short course of outpatient pulmonary rehabilitation and management of
COPD according to international guidelines. Participants were provided a telephone
number of a healthcare provider for seeking advice. In addition, they received 3-monthly
telephone calls. Completion rate of pulmonary rehabilitation sessions: 71%. Follow-up:
12 months
Usual care: conventionalmedical treatment and follow-up as per normal practice. Follow-
up: 12 months
Outcomes Hospital readmission rate (primary outcome); SGRQ, 6MWD, mortality (secondary
outcomes)
Notes Pulmonary rehabilitation programme was considered extensive (downgraded by -1 for
some unsupervised training and upgraded by +1 for comprehensive self-management
programme)
Clinical trial identifier: NCT01108835
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Minimisation was used that considered 5 potential
confounders
Allocation concealment (selection bias) Low risk By using minimisation, investigators ensured alloca-
tion concealment
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information about who collected the data not avail-
able from trial report
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Although unavoidable by definition, lack of blinding
may affect outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information about who collected the data not avail-
able from trial report. Outcome unlikely to be af-
fected by knowledge of treatment group assignment
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Ko 2016 (Continued)
Blinding (performance bias and detection
bias)
Walk test
Low risk “the research assistant performing walking tests was
neither involved in the delivery of the patient care
nor aware of the randomization process/”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups. “Analyses were conducted ac-
cording to intention-to-treat principle.”
Selective reporting (reporting bias) Low risk Information is reported in a sufficiently complete and
transparent way. Clinical trial number reported
Other bias Unclear risk Unclear further potential bias
Liao 2015
Methods Randomised parallel-group trial
Participants 61 participants with COPD (mean age 70 years, 61% males, no FEV1 data) admitted
to hospital for a COPD exacerbation
Interventions Rehabilitation: inpatient respiratory rehabilitation exercise training package consisting
of walk training (2 sessions/d, 10 to 30 minutes per session), disease awareness, sputum
clearance treatment, pursed lip breathing, upper limb exercise with deep breathing and
nutrition management and health education. Follow-up: 4 days
Usual care: health education. Follow-up: 4 days
Outcomes 6MWD
Notes Pulmonary rehabilitation programmewas consideredmoderately extensive (downgraded
by -2 for < 10 exercise sessions; upgraded by +1 for comprehensive self-management
training)
Financial support provided by the Chest Hospital, Ministry of Health and Welfare,
Taiwan (DOH100-HO-3053)
Clinical trial identifier: NCT02329873
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Described as randomised via a coin toss
Allocation concealment (selection bias) Unclear risk Information not available from trial report
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Liao 2015 (Continued)
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not reported. Outcome not assessed
Blinding (performance bias and detection
bias)
Health-related quality of life
Unclear risk Information not reported. Outcome not assessed
Blinding (performance bias and detection
bias)
Mortality
Unclear risk Information not reported. Outcome not assessed
Blinding (performance bias and detection
bias)
Walk test
Unclear risk Information not available from trial report. Although
unavoidable by definition, lack of blindingmay affect
outcome
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups
Selective reporting (reporting bias) Low risk Information is reported in a sufficiently complete and
transparent way. Clinical trial number reported
Other bias Low risk No indication of other biases
Man 2004
Methods Randomised parallel-group trial
Participants 42 participants with COPD (mean age 70 years, 41% males, FEV1 39% predicted) after
inpatient treatment for acute exacerbation
Interventions Rehabilitation:multi-disciplinary outpatient pulmonary rehabilitation (within 10 days
of discharge) with endurance and strength exercise and patient education for 8 weeks (2
sessions/wk). Completion rate of pulmonary rehabilitation: 85.7% (18/21 participants)
Usual care: standard community care with respirologist. Follow-up: 12 weeks
Outcomes CRQ, SGRQ, ISWT, hospital readmission, hospital days, emergency admissions, mor-
tality
Notes Pulmonary rehabilitation programme was considered extensive (upgraded by +1 for
extensive self-management training)
Financial support provided by theBritish Lung FoundationTrevorClayMemorialGrant.
and by “Pursuing Perfection,” co-ordinated by the NHS Modernisation Agency
Risk of bias
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Man 2004 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A random number generator was our tool to assign
an intervention to the first patient entering the study.
We used the minimisation method to assign patients
further to the intervention group, taking into account
five factors: age (< 70 years or 70 years), sex, length of
hospital admission (< 7 days or 7 days), incremental
shuttle walk distance at discharge (< 100 metres or
100 metres), and predicted forced expiratory volume
in one second (FEV1; < 30% or 30%).”
Allocation concealment (selection bias) Low risk Used minimisation when allocation was concealed
Blinding (performance bias and detection
bias)
Hospital admission
High risk Lack of blinding may affect outcome assessment.
“Owing to the nature of the intervention... it was not
possible to blind the patients or the assessors (inves-
tigator responsible and members of the pulmonary
rehabilitation team).”
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Although unavoidable by definition, lack of blinding
may affect outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
High risk Lack of blinding likely to affect outcome assessment.
“Owing to the nature of the intervention... it was not
possible to blind the patients or the assessors (inves-
tigator responsible and members of the pulmonary
rehabilitation team).”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups
“We analysed data on intention to treat basis. We
made no attempt to impute missing data from those
participants who were lost to follow up.”
Selective reporting (reporting bias) Unclear risk Information is reported in a sufficiently complete and
transparent way. Clinical trial number not reported
Other bias Low risk No indication of other biases
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Murphy 2005
Methods Randomised parallel-group trial
Participants 26 participants with COPD (mean age 66 years, 65%males,mean FEV1 40% predicted)
after home-for-hospital treatment for acute exacerbation
Interventions Rehabilitation: supervised home-based pulmonary rehabilitation with endurance and
strength exercise for 6 weeks (2 supervised sessions/wk and daily unsupervised sessions)
. Completion rate of pulmonary rehabilitation: 76.9% (10/13 participants)
Usual care: standard community care with respirologist. Follow-up: 26 weeks
Outcomes SGRQ, EQ-5D, ISWT, 3-minute step test, hospital readmission
Notes Dr Murphy provided standard deviations for SGRQ measurements
Pulmonary rehabilitation programmewas consideredmoderately extensive (downgraded
by -1 for 10 to 15 exercise training sessions)
Financial support not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomised” - Although the process of generating
the randomisation schedule was not specified, it was
presumed done because of efforts made with alloca-
tion concealment
Allocation concealment (selection bias) Low risk “...each patient was randomly assigned in a 1:1 ratio
for the home exercise group or a control group (stan-
dard care group) using blinded sealed envelopes.”
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Although unavoidable by definition, lack of blinding
may affect outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
Unclear risk Information not provided in trial report. Potential
lack of blinding likely to affect outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are detailed for both groups, and
the final number of participants is balanced between
comparison groups
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Murphy 2005 (Continued)
Selective reporting (reporting bias) Unclear risk Information is reported in a sufficiently complete and
transparent way. Clinical trial number not reported
Other bias Low risk No indication of other biases
Nava 1998
Methods Randomised parallel-group trial
Participants 70 participants with COPD (mean age 66 years, 73%males, mean FEV1 32% predicted,
76% needed mechanical ventilation) admitted to inpatient care for treatment of acute
exacerbation
Interventions Rehabilitation: within 3 to 5 days after admission, inpatient pulmonary rehabilitation
with 4 steps of increasing intensity
Step I, if unable to walk: mobilisation and strength training for lower extremities
Step II, if able to walk: endurance exercise (walking)
Step III, if possible: endurance exercise (cycling and stair climbing) and respiratorymuscle
training
Step IV, if possible: endurance exercise (cycling at highest tolerated intensity, 2 sessions/
d for 3 weeks)
Completion rate of pulmonary rehabilitation: 85.4% (41/48 participants)
Usual care: only steps I and II. Follow-up: 6 weeks
Outcomes 6MWD, mortality
Notes Pulmonary rehabilitation programme was considered extensive (upgraded by +1 for >
30 exercise sessions)
Financial support not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Described as randomised via a computer programme;
additional information not available from trial report
Allocation concealment (selection bias) Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Information not available from trial report. Although
unavoidable by definition, lack of blindingmay affect
outcome
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Nava 1998 (Continued)
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
Unclear risk Information not provided in trial report. Potential
lack of blinding likely to affect outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Losses to follow-up are not specified. The final num-
ber of participants is balanced between groups ac-
cording to 3:1 randomisation (intervention group n
= 60 and control group n = 20)
Selective reporting (reporting bias) Unclear risk Outcome reporting is sufficiently complete and trans-
parent. Clinical trial registration number not re-
ported
Other bias Low risk No indication of other biases
Seymour 2010
Methods Randomised parallel-group trial
Participants 60 participants with COPD (mean age 66 years, 82%males,mean FEV1 52% predicted)
after inpatient treatment of acute exacerbation
Interventions Rehabilitation: within a week after hospital discharge, outpatient pulmonary rehabil-
itation twice-weekly exercise (limb strengthening and aerobic activities) and education
sessions, during 8 weeks. Completion rate of pulmonary rehabilitation: 77% (23/30).
Participants were provided general information about COPD and were offered outpa-
tient appointments with general practitioner or respiratory team. Follow-up: 12 weeks
Usual care: Participants were provided general information about COPD and were of-
fered outpatient appointments with general practitioner or respiratory team.Not referred
further Follow-up: 12 weeks
Outcomes Exacerbation with hospitalisation (primary outcome), ISWT, ESWT, CRQ and SGRQ
(secondary)
Notes Pulmonary rehabilitation programme was considered extensive (downgraded by -1 for
10 to 15 exercise training sessions, and upgraded by +1 for extensive self-management
training)
Financial support provided by the British Lung Foundation
Clinical trial identifier: NCT00557115
Risk of bias
Bias Authors’ judgement Support for judgement
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Seymour 2010 (Continued)
Random sequence generation (selection
bias)
Low risk “Participants were allocated by concealed randomi-
sation by a statistician. The minimisation method
matched groups for age (< 70 years or ≥ 70 years),
sex (male or female), predicted FEV1 (< 30% or ≥
30%), duration of admission (< 7 or ≥ 7 days) and
baseline ISWT (< 100 m or ≥ 100 m).”
Allocation concealment (selection bias) Low risk Used minimisation when allocation was concealed
Blinding (performance bias and detection
bias)
Hospital admission
High risk Authors state: “Due to the nature of the intervention,
it was not possible to blind subjects to their allocation.
”
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk “Due to the nature of the intervention, it was not
possible to blind subjects to their allocation.”
Although unavoidable by definition, lack of blinding
may affect outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
High risk Authors state: “Due to the nature of the intervention,
it was not possible to blind subjects to their allocation.
”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are well specified, and the final
number of participants is balanced between compar-
ison groups
“Participants were analysed on an intention-to-treat
basis regardless of compliance.”
Selective reporting (reporting bias) Low risk Outcome reporting is sufficiently complete and trans-
parent: Results for all listed primary and secondary
outcomes were reported. Clinical trial registration
number reported
Other bias Low risk No indication of other biases
Tang 2012
Methods Randomised parallel-group trial
Participants 32 participants with COPD (CG: mean age 78 years, 55% males, mean FEV1 47%
predicted; low-Intensity IG: mean age 68 years, 45% males, mean FEV1 45% predicted;
high-Intensity IG: mean age 74 years, 20% males, mean FEV1 46% predicted) after
inpatient treatment of acute exacerbation
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Tang 2012 (Continued)
Interventions Rehabilitation: Within 2 days after admission, inpatient exercise programme followed
twice-daily 15-minute exercise sessions, in addition to standard physical therapy treat-
ment. Low-intensity group walked at 40% and high-intensity group at 70% of the 3-
minute walk test for 7.5 minutes; upper and lower limb resistance exercise was also done.
Adherence to pulmonary rehabilitation was 78% in the low-intensity group and 71% in
the high-intensity group. Follow-up: until hospital discharge
Usual care: once-daily physical therapy (sputum clearance techniques, mobility and
functional training)
Outcomes Adverse events (primary outcome), 3MWD (secondary outcome)
Notes Pulmonary rehabilitation programme was considered slightly extensive (downgraded by
-2 for < 10 exercise training sessions)
Financial support not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “A block randomisation allocation sequence was gen-
erated using a web-based program.”
Allocation concealment (selection bias) Unclear risk “Principal investigator unsealed envelopes sequen-
tially and allocated patients after baseline assessment.
”
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Health-related quality of life
Unclear risk Infromation not reported
Blinding (performance bias and detection
bias)
Mortality
Unclear risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
Unclear risk “RCT blinded to baseline and discharge assessments”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are specified, and the final num-
ber of participants is balanced between comparison
groups
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Tang 2012 (Continued)
Selective reporting (reporting bias) Low risk Outcome reporting is sufficiently complete and trans-
parent: Results for all listed primary and secondary
outcomes were reported. Clinical trial registration
number not reported
Other bias Low risk No indication of other biases
Torres-Sánchez 2014
Methods Randomised parallel-group trial
Participants 60 participants with COPD (mean age 71 years, 93% males, FEV1 not reported) ad-
mitted for treatment of non-infectious exacerbation
Interventions Rehabilitation: daily resistance lower limbs and controlled breathing exercises for 45
minutes. No other information reported
Usual care: standard medical treatment
Outcomes SGRQ
Notes Information extracted from conference meeting abstract. Study authors have not pub-
lished the data
Extensiveness of pulmonary rehabilitation programme could not be assessed
Financial support not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “were randomly allocated to a control or an interven-
tion group”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Not reported
Blinding (performance bias and detection
bias)
Health-related quality of life
Unclear risk Not reported
Blinding (performance bias and detection
bias)
Mortality
Unclear risk Not reported
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Torres-Sánchez 2014 (Continued)
Blinding (performance bias and detection
bias)
Walk test
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk Not reported
Other bias Unclear risk Not reported
Torres-Sánchez 2015
Methods Randomised parallel-group trial
Participants 49 participants with COPD and body mass index (BMI) ≥ 30 kg/cm2 and admitted to
the hospital for≥ 7 days for a COPD exacerbation (CG: mean age 74 years, 91% males,
mean FEV1 41% predicted, mean BMI 34 kg/cm2; IG: mean age 72 years, 100% males,
mean FEV1 39% predicted, mean BMI 34 kg/cm2
Interventions Rehabilitation: twice-daily individualised and supervised multi-modal PR during 30 to
45 minutes. Programme included deep breathing, range of motion and upper and lower
limb muscle strengthening exercises and 20 to 30 minutes of limb exercises. Adherence
to PR not reported, but participants needed ≥ 7 training sessions to be considered for
the analyses. It is unclear how many participants were excluded because they completed
fewer than 7 sessions.
Usual care: standard medical therapy, including systemic steroids, inhaled bronchodila-
tors and oxygen
Outcomes 2-Minute step-in-place test, EuroQol (EQ-5D)
Notes Pulmonary rehabilitation programmewas consideredmoderately extensive (downgraded
by -1 for 10 to 15 exercise training sessions)
Financial support provided by the professional association of physiotherapists of Andalu-
sia, Spain (Colegio Profesional de Fisioterapeutas de Andalucía) and the Spanish Society
of Pneumology and Thoracic Surgery (SEPAR) and the Spanish Foundation of the Lung
(Fundación Respira)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation list
Allocation concealment (selection bias) Low risk An independent nurse assigned participants to IG
or CG according to a computer-generated randomi-
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Torres-Sánchez 2015 (Continued)
sation list. The nurse informed the physiotherapist
once participants had given their approval to partic-
ipate in the study
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk NA
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Although unavoidable by definition, lack of blinding
may affect outcome
Blinding (performance bias and detection
bias)
Mortality
Unclear risk NA
Blinding (performance bias and detection
bias)
Walk test
Unclear risk Unclear who supervised the 2-minute step-in-place
test
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Adherence to PR not reported, but participants
needed≥ 7 training sessions to be considered for the
analyses. It is unclear howmany participants were ex-
cluded because they completed fewer than 7 sessions
Selective reporting (reporting bias) Unclear risk Unclear if some measures taken at baseline (e.g.
SGRQ) were not used as outcomes
Other bias Unclear risk No indication of other biases
Troosters 2002
Methods Randomised parallel-group trial
Participants 43 participants with COPD (mean age 62 years, 85% males, FEV1 39% predicted) after
inpatient treatment for acute exacerbation
Interventions Rehabilitation: outpatient pulmonary rehabilitation with endurance and strength ex-
ercise for 6 months (3 sessions/wk in first 3 months, then 2 sessions/wk). Completion
rate of pulmonary rehabilitation: 70.8% (17/24 participants)
Usual care: standard community care with respirologist (not further specified). Follow-
up: 208 weeks
Outcomes 6MWD, mortality
Notes Pulmonary rehabilitation programme was considered extensive (upgraded by +1 for >
30 exercise sessions)
Financial support provided by the Fonds voorWetenschappelijk Onderzoek-Vlaanderen
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Troosters 2002 (Continued)
(G0189.97 and G0175.99), Levenslijn Grant 7.0002.94, and Onderzoeksfonds, KU
Leuven, Grant 27/98
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised; additional information not
available from trial report
Allocation concealment (selection bias) Unclear risk Information not available from trial report
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Health-related quality of life
High risk Information not provided in trial report. Although
unavoidable by definition, lack of blindingmay affect
outcome
Blinding (performance bias and detection
bias)
Mortality
Low risk Information not available from trial report.Outcome
unlikely to be affected by knowledge of treatment
group assignment
Blinding (performance bias and detection
bias)
Walk test
Unclear risk Information not provided in trial report. Potential
lack of blinding likely to affect outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses to follow-up are specified, and the final num-
ber of participants is balanced between comparison
groups
Selective reporting (reporting bias) Unclear risk Outcome reporting is sufficiently complete and trans-
parent. Clinical trial registration number not re-
ported
Other bias Low risk No indication of other biases
Troosters 2010
Methods Randomised parallel-group trial
Participants 36 participants with COPD (CG: n = 19, mean age 69 years, 74% males, FEV1 50%
predicted; IG: n = 17, mean age 67 years, 76% males, FEV1 40% predicted) admitted
for treatment for acute exacerbation
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Troosters 2010 (Continued)
Interventions Rehabilitation: daily quadriceps resistance training for 7 days. Follow-up: 8 days
Usual care:medical usual care plus mucous secretion clearance techniques and breathing
exercises. Follow-up: 8 days
Outcomes 6MWD
Notes Pulmonary rehabilitation programme was considered not extensive (downgraded by -2
for < 10 exercise training sessions, and by -1 when only strength training was offered)
Financial support provided by the Research Foundation, Flanders grants KAN 1.5.139.
06N and G.0386.05N
Clinical trial identifier: NCT00877084
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as randomised via “opaque envelopes pre-
pared by an independent secretary”
Allocation concealment (selection bias) High risk “Tests were performed by researchers who were not
blind to the allocation of the patients.”
Blinding (performance bias and detection
bias)
Hospital admission
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Health-related quality of life
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Mortality
Unclear risk Information not reported
Blinding (performance bias and detection
bias)
Walk test
High risk Researchers and participants were not blind to the
allocation group
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Losses to follow-up are not specified, although the fi-
nal number of participants is balanced between com-
parison groups
Selective reporting (reporting bias) Low risk Outcome reporting is sufficiently complete and trans-
parent. Clinical trial registration number reported
Other bias Low risk Supplemental material on methods and analysis re-
ported. No indication of other biases
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3MWD: three-minute walking distance; 6MWD: six-minute walking distance; ATS: American Thoracic Society; BMI: body mass
index; BODE index: body mass index, airflow obstruction, dyspnoea and exercise capacity index; CG: control group; COPD:
chronic obstructive pulmonary disease; CRQ: Chronic Respiratory Questionnaire; EQ-5D: EuroQoL questionnaire; ERS: European
Respiratory Society; ESWT: endurance shuttle walk test; FEV1: forced expiratory volume in one second; h: hour; IG: intervention
group; ISWT: incremental shuttle walk test; SF-36: short-form health survey; SGRQ: St George’s Respiratory Questionnaire.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ali 2014 Not a randomised trial
Aljassem 2012 Not a randomised trial
Babu 2010 No control group without exercise training
Benzo 2015 Did not study intervention but provided reasons for non-participation in a trial
Puhan 2012 No control group without rehabilitation
Rasekaba 2009 Not a randomised trial
Saey 2011 Comment on Troosters 2010 trial
Tang 2013 Qualitative results from Tang 2012 trial
Torres-Sánchez 2013 Not a randomised trial
Zheng 2012 Not a randomised trial
Characteristics of ongoing studies [ordered by study ID]
Beekman 2014
Trial name or title Reducing Exacerbations in Patients With Chronic Obstructive Pulmonary Disease With Physiotherapy
Methods
Participants
Interventions
Outcomes
Starting date
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Beekman 2014 (Continued)
Contact information
Notes Study ongoing
Castelain 2008
Trial name or title Early Rehabilitation of COPD Patients in ICU
Methods
Participants
Interventions
Outcomes
Starting date
Contact information
Notes Study has been terminated. No data published
Hughes 2015
Trial name or title Pulmonary Rehabilitation and ACTIvity after COPD Exacerbations: the PRACTICE trial
Methods
Participants
Interventions
Outcomes
Starting date
Contact information
Notes Recruiting participants
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Knaut 2014
Trial name or title Evaluation of Aerobic Exercise Program During Hospitalization in Quality of Life and in Exercise Capacity
After One Month of Discharge in Exacerbated COPD
Methods
Participants
Interventions
Outcomes
Starting date
Contact information
Notes Abstracts/22nd Annual Congress, Munich, Germany, 6-10 September 2014
Morante 2013
Trial name or title Impact of Early Respiratory Rehabilitation in the Exacerbations of Re-admitted COPD Patients
Methods
Participants
Interventions
Outcomes
Starting date
Contact information
Notes Recruiting participants
Spielmanns 2015
Trial name or title Effect of Pneumological Rehabilitation After an Acute Exacerbation of COPD (Chronic Obstructive Pul-
monary Disease)
Methods
Participants
Interventions
Outcomes
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Spielmanns 2015 (Continued)
Starting date
Contact information
Notes Not recruiting
Stickland 2015
Trial name or title Examining Pulmonary Rehabilitation on Discharged COPD Patients
Methods
Participants
Interventions
Outcomes
Starting date
Contact information
Notes Recruiting participants
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D A T A A N D A N A L Y S E S
Comparison 1. Rehabilitation versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Hospital readmission (to end of
follow-up)
8 810 Odds Ratio (M-H, Random, 95% CI) 0.44 [0.21, 0.91]
2 Mortality 6 670 Odds Ratio (M-H, Random, 95% CI) 0.68 [0.28, 1.67]
3 Health-related quality of life:
Chronic Respiratory Disease
Questionnaire (CRQ)
5 Mean Difference (Random, 95% CI) Subtotals only
3.1 CRQ: dyspnoea domain 5 Mean Difference (Random, 95% CI) 0.97 [0.35, 1.58]
3.2 CRQ: fatigue domain 5 Mean Difference (Random, 95% CI) 0.81 [0.16, 1.45]
3.3 CRQ: emotional function
domain
5 Mean Difference (Random, 95% CI) 0.94 [0.46, 1.42]
3.4 CRQ: mastery domain 5 Mean Difference (Random, 95% CI) 0.93 [-0.13, 1.99]
4 Health-related quality of
life: St George’s Respiratory
Questionnaire
8 Mean Difference (Random, 95% CI) Subtotals only
4.1 SGRQ: total 8 Mean Difference (Random, 95% CI) -7.80 [-12.12, -3.47]
4.2 SGRQ: impact 8 Mean Difference (Random, 95% CI) -10.44 [-16.11, -4.
76]
4.3 SGRQ: symptoms 8 Mean Difference (Random, 95% CI) -2.45 [-7.33, 2.42]
4.4 SGRQ: activity limitation 8 Mean Difference (Random, 95% CI) -8.23 [-12.88, -3.57]
5 Change from baseline in 6-
minute walking test
13 Mean Difference (Random, 95% CI) 62.38 [38.45, 86.31]
6 Change from baseline in shuttle
walk test
4 Mean Difference (Random, 95% CI) 48.14 [-1.03, 97.32]
7 Subgroup analysis hospital
readmission: extensiveness of
rehabilitation programme
8 810 Odds Ratio (M-H, Random, 95% CI) 0.44 [0.21, 0.91]
7.1 Extensive rehab
programmes
5 367 Odds Ratio (M-H, Random, 95% CI) 0.28 [0.10, 0.78]
7.2 Less-extensive rehab
programmes
3 443 Odds Ratio (M-H, Random, 95% CI) 0.92 [0.44, 1.93]
8 Subgroup analysis hospital
readmission: length of follow-
up
8 587 Odds Ratio (M-H, Random, 95% CI) 0.41 [0.22, 0.76]
8.1 Follow-up >3 months 5 389 Odds Ratio (M-H, Random, 95% CI) 0.51 [0.24, 1.06]
8.2 Follow-up ≤3 months 3 198 Odds Ratio (M-H, Random, 95% CI) 0.24 [0.06, 0.98]
9 Subgroup analysis hospital
readmission: generation of
random sequence
8 810 Odds Ratio (M-H, Random, 95% CI) 0.44 [0.21, 0.91]
9.1 Low risk of bias 6 758 Odds Ratio (M-H, Random, 95% CI) 0.55 [0.25, 1.19]
9.2 Unclear or high risk of
bias
2 52 Odds Ratio (M-H, Random, 95% CI) 0.16 [0.04, 0.59]
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10 Subgroup analysis hospital
readmission: concealment of
random allocation
8 810 Odds Ratio (M-H, Random, 95% CI) 0.44 [0.21, 0.91]
10.1 Low risk of bias 7 784 Odds Ratio (M-H, Random, 95% CI) 0.52 [0.25, 1.08]
10.2 Unclear or high risk of
bias
1 26 Odds Ratio (M-H, Random, 95% CI) 0.09 [0.01, 0.56]
11 Subgroup analysis hospital
readmission: blinding
8 810 Odds Ratio (M-H, Random, 95% CI) 0.44 [0.21, 0.91]
11.1 Low risk of bias 0 0 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
11.2 Unclear or high risk of
bias
8 810 Odds Ratio (M-H, Random, 95% CI) 0.44 [0.21, 0.91]
12 Subgroup analysis mortality:
extensiveness of rehabilitation
programme
6 670 Odds Ratio (M-H, Random, 95% CI) 0.68 [0.28, 1.67]
12.1 Extensive rehab
programmes
5 350 Odds Ratio (M-H, Random, 95% CI) 0.50 [0.26, 0.99]
12.2 Less-extensive rehab
programmes
1 320 Odds Ratio (M-H, Random, 95% CI) 1.88 [1.06, 3.33]
13 Subgroup analysis mortality:
length of follow-up
6 670 Odds Ratio (M-H, Random, 95% CI) 0.68 [0.28, 1.67]
13.1 Follow-up >3 months 5 629 Odds Ratio (M-H, Random, 95% CI) 0.69 [0.26, 1.86]
13.2 Follow-up ≤3 months 1 41 Odds Ratio (M-H, Random, 95% CI) 0.5 [0.04, 5.99]
14 Subgroup analysis mortality:
generation of random sequence
6 670 Odds Ratio (M-H, Random, 95% CI) 0.68 [0.28, 1.67]
14.1 Low risk of bias 4 601 Odds Ratio (M-H, Random, 95% CI) 1.10 [0.52, 2.34]
14.2 Unclear or high risk of
bias
2 69 Odds Ratio (M-H, Random, 95% CI) 0.25 [0.08, 0.83]
15 Subgroup analysis mortality:
concealment of random
allocation
6 670 Odds Ratio (M-H, Random, 95% CI) 0.68 [0.28, 1.67]
15.1 Low risk of bias 4 601 Odds Ratio (M-H, Random, 95% CI) 1.10 [0.52, 2.34]
15.2 Unclear or high risk of
bias
2 69 Odds Ratio (M-H, Random, 95% CI) 0.25 [0.08, 0.83]
16 Subgroup analysis mortality:
blinding
6 670 Odds Ratio (M-H, Random, 95% CI) 0.68 [0.28, 1.67]
16.1 Low risk of bias 6 670 Odds Ratio (M-H, Random, 95% CI) 0.68 [0.28, 1.67]
16.2 Unclear or high risk of
bias
0 0 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
17 Subgroup analysis
CRQ dyspnoea domain:
extensiveness of rehabilitation
programme
5 Mean Difference (Random, 95% CI) Subtotals only
17.1 Extensive rehab
programmes
3 Mean Difference (Random, 95% CI) 1.31 [0.63, 2.00]
17.2 Less-extensive rehab
programmes
2 Mean Difference (Random, 95% CI) 0.37 [-0.50, 1.24]
18 Subgroup analysis CRQ
dyspnoea domain: length of
follow-up
5 Mean Difference (Random, 95% CI) 0.97 [0.35, 1.58]
18.1 Follow-up >3 months 1 Mean Difference (Random, 95% CI) 2.44 [1.42, 3.46]
18.2 Follow-up ≤3 months 4 Mean Difference (Random, 95% CI) 0.70 [0.12, 1.28]
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19 Subgroup analysis CRQ
dyspnoea domain: generation
of random sequence
5 Mean Difference (Random, 95% CI) 0.97 [0.35, 1.58]
19.1 Low risk of bias 3 Mean Difference (Random, 95% CI) 0.65 [-0.07, 1.37]
19.2 Unclear or high risk of
bias
2 Mean Difference (Random, 95% CI) 1.65 [0.14, 3.16]
20 Subgroup analysis CRQ
dyspnoea domain: concealment
of random allocation
5 Mean Difference (Random, 95% CI) 0.97 [0.35, 1.58]
20.1 Low risk of bias 3 Mean Difference (Random, 95% CI) 0.65 [-0.07, 1.37]
20.2 Unclear or high risk of
bias
2 Mean Difference (Random, 95% CI) 1.65 [0.14, 3.16]
21 Subgroup analysis CRQ
dyspnoea domain: blinding
5 Mean Difference (Random, 95% CI) 0.97 [0.35, 1.58]
21.1 Low risk of bias 0 Mean Difference (Random, 95% CI) 0.0 [0.0, 0.0]
21.2 Unclear or high risk of
bias
5 Mean Difference (Random, 95% CI) 0.97 [0.35, 1.58]
22 Subgroup analysis SGRQ
total score: extensiveness of
rehabilitation programme
8 Mean Difference (Random, 95% CI) Subtotals only
22.1 Extensive rehab
programmes
4 Mean Difference (Random, 95% CI) -7.82 [-11.03, -4.61]
22.2 Less-extensive rehab
programmes
4 Mean Difference (Random, 95% CI) -8.49 [-18.13, 1.15]
23 Subgroup analysis SGRQ total
score: length of follow-up
8 Mean Difference (Random, 95% CI) -7.80 [-12.12, -3.47]
23.1 Follow-up >3 months 4 Mean Difference (Random, 95% CI) -4.27 [-8.32, -0.22]
23.2 Follow-up ≤3 months 4 Mean Difference (Random, 95% CI) -12.09 [-17.61, -6.
57]
24 Subgroup analysis SGRQ total
score: generation of random
sequence
8 Mean Difference (Random, 95% CI) -7.80 [-12.12, -3.47]
24.1 Low risk of bias 6 Mean Difference (Random, 95% CI) -5.87 [-9.87, -1.88]
24.2 Unclear or high risk of
bias
2 Mean Difference (Random, 95% CI) -14.32 [-25.35, -3.
29]
25 Subgroup analysis SGRQ total
score: concealment of random
allocation
8 Mean Difference (Random, 95% CI) -7.80 [-12.12, -3.47]
25.1 Low risk of bias 7 Mean Difference (Random, 95% CI) -6.12 [-9.73, -2.51]
25.2 Unclear or high risk of
bias
1 Mean Difference (Random, 95% CI) -20.06 [-28.00, -10.
12]
26 Subgroup analysis SGRQ total
score: blinding
8 Mean Difference (Random, 95% CI) -7.80 [-12.12, -3.47]
26.1 Low risk of bias 0 Mean Difference (Random, 95% CI) 0.0 [0.0, 0.0]
26.2 Unclear or high risk of
bias
8 Mean Difference (Random, 95% CI) -7.80 [-12.12, -3.47]
27 Subgroup analysis 6-minute
walking test: extensiveness of
rehabilitation programme
13 Mean Difference (Random, 95% CI) 59.70 [35.09, 84.31]
27.1 Extensive rehab
programmes
6 Mean Difference (Random, 95% CI) 65.50 [31.71, 99.30]
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27.2 Less-extensive rehab
programmes
7 Mean Difference (Random, 95% CI) 54.91 [6.07, 103.74]
28 Subgroup analysis 6-minute
walk test: length of follow-up
13 Mean Difference (Random, 95% CI) 59.70 [35.09, 84.31]
28.1 Follow-up >3 months 4 Mean Difference (Random, 95% CI) 78.95 [1.95, 155.96]
28.2 Follow-up ≤3 months 9 Mean Difference (Random, 95% CI) 52.21 [24.72, 79.70]
29 Subgroup analysis 6-minute
walk test: generation of random
sequence
13 Mean Difference (Random, 95% CI) 59.70 [35.09, 84.31]
29.1 Low risk of bias 7 Mean Difference (Random, 95% CI) 34.89 [14.17, 55.61]
29.2 Unclear or high risk of
bias
6 Mean Difference (Random, 95% CI) 86.44 [25.63, 147.
24]
30 Subgroup analysis 6-minute
walk test: concealment of
random allocation
13 Mean Difference (Random, 95% CI) 62.38 [38.44, 86.32]
30.1 Low risk of bias 5 Mean Difference (Random, 95% CI) 29.55 [6.15, 52.95]
30.2 Unclear or high risk of
bias
8 Mean Difference (Random, 95% CI) 84.16 [40.23, 128.
09]
31 Subgroup analysis 6-minute
walk test: blinding
13 Mean Difference (Random, 95% CI) 62.38 [38.44, 86.32]
31.1 Low risk of bias 3 Mean Difference (Random, 95% CI) 26.31 [-30.62, 83.
25]
31.2 Unclear or high risk of
bias
10 Mean Difference (Random, 95% CI) 74.02 [44.81, 103.
23]
32 Subgroup analysis shuttle
walk test: extensiveness of
rehabilitation programme
4 Mean Difference (Random, 95% CI) 47.10 [-4.53, 98.74]
32.1 Extensive rehab
programmes
2 Mean Difference (Random, 95% CI) 58.45 [35.02, 81.88]
32.2 Less-extensive rehab
programmes
2 Mean Difference (Random, 95% CI) 35.32 [-77.20, 147.
85]
33 Subgroup analysis shuttle walk
test: length of follow-up
4 Mean Difference (Random, 95% CI) 48.14 [-1.03, 97.32]
33.1 Follow-up >3 months 2 Mean Difference (Random, 95% CI) 37.68 [-69.92, 145.
28]
33.2 Follow-up ≤3 months 2 Mean Difference (Random, 95% CI) 58.77 [34.85, 82.69]
34 Subgroup analysis shuttle walk
test: generation of random
sequence
4 Mean Difference (Random, 95% CI) 48.14 [-1.03, 97.32]
34.1 Low risk of bias 3 Mean Difference (Random, 95% CI) 35.41 [-18.04, 88.
86]
34.2 Unclear or high risk of
bias
1 Mean Difference (Random, 95% CI) 96.0 [37.20, 154.80]
35 Subgroup analysis shuttle walk
test: concealment of random
allocation
4 Mean Difference (Random, 95% CI) 48.14 [-1.03, 97.32]
35.1 Low risk of bias 4 Mean Difference (Random, 95% CI) 48.14 [-1.03, 97.32]
35.2 Unclear or high risk of
bias
0 Mean Difference (Random, 95% CI) 0.0 [0.0, 0.0]
36 Subgroup analysis shuttle walk
test: blinding
4 Mean Difference (Random, 95% CI) 48.14 [-1.03, 97.32]
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36.1 Low risk of bias 1 Mean Difference (Random, 95% CI) -14.0 [-39.48, 11.
48]
36.2 Unclear or high risk of
bias
3 Mean Difference (Random, 95% CI) 64.58 [41.49, 87.66]
37 Hospital readmission (to end of
follow-up) with separated new
trial data
8 810 Odds Ratio (M-H, Random, 95% CI) 0.44 [0.21, 0.91]
37.1 Existing trials 5 250 Odds Ratio (M-H, Random, 95% CI) 0.22 [0.08, 0.58]
37.2 New trials added 3 560 Odds Ratio (M-H, Random, 95% CI) 0.93 [0.38, 2.26]
38 Mortality with separated new
trial data
6 670 Odds Ratio (M-H, Random, 95% CI) 0.68 [0.28, 1.67]
38.1 Existing trials 3 110 Odds Ratio (M-H, Random, 95% CI) 0.28 [0.10, 0.84]
38.2 New trials added 3 560 Odds Ratio (M-H, Random, 95% CI) 1.14 [0.48, 2.71]
39 Health-related quality of life:
SGRQ total with separated
new trial data
8 Mean Difference (Random, 95% CI) -7.80 [-12.12, -3.47]
39.1 Existing trials 3 Mean Difference (Random, 95% CI) -9.88 [-14.40, -5.37]
39.2 New trials added 5 Mean Difference (Random, 95% CI) -6.68 [-12.83, -0.53]
40 Change from baseline in 6
minute walking test with
separated new trial data
13 Mean Difference (Random, 95% CI) 62.35 [38.45, 86.25]
40.1 Existing trials 6 Mean Difference (Random, 95% CI) 77.70 [12.21, 143.
20]
40.2 New trials added 7 Mean Difference (Random, 95% CI) 48.00 [28.32, 67.68]
A D D I T I O N A L T A B L E S
Table 1. Extensiveness of pulmonary rehabilitation programmes of included trials
Study Number of
sessions
Trainings per week Rehabilitation
programme
Supervision of
training
Extent of rehabili-
tation programme
Behnke 2000 +1a (p 1185) - - -1b (p 1185) Extensive
Borges 2014 -2c (p 1642) - -1d (p 1639) - Not extensive
Carr 2009 -1e (p 320-1) - - - Moderately exten-
sive
Deepak 2014 Unclearf Unclear - - Unclear
Eaton 2009 -2c (p 231-2) - +1g (p 231) - Moderately exten-
sive
Greening 2014 - - +1g (p 3) -2h (p 3-4) Moderately exten-
sive
He 2015 - Extensive
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Table 1. Extensiveness of pulmonary rehabilitation programmes of included trials (Continued)
Kirsten 1998 - - - -1b (p 1193) Moderately exten-
sive
Ko 2011 - - - - Extensive
Ko 2016 - - +1g (p 6) -1b (p 7) Extensive
Liao 2015 -2c (p 1706) - +1g (p 1705) - Moderately exten-
sive
Man 2004 - - +1f (p 2) - Extensive
Murphy 2005 -1e (p 1298) - - - Moderately exten-
sive
Nava 1998 +1a (p 850-1) - - - Extensive
Seymour 2010 -1e (p 423 & 425) - +1f (p 423) - Extensive
Tang 2012 -2c (p 164 & 167) - - - Slightly extensive
Torres-Sánchez
2014
Unclear Unclear Unclear Unclear Unclear
Torres-Sánchez
2015
-1e (p 3) - - - Moderately exten-
sive
Troosters 2002 +1a (p 208-9) - - - Extensive
Troosters 2010 -2c (p 1073-4) - -1d (p 1073) - Not extensive
Explanations for downgrading and upgrading
a(> 30 sessions).
bSome training sessions unsupervised.
c< 10 exercise training sessions.
dOnly strength training.
e10 to 15 exercise training sessions.
f 14 weeks, but unclear number of sessions per week.
gComprehensive self-management training.
hMostly unsupervised training (> 80% of all sessions).
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F E E D B A C K
Details of interventions administered in the studies, 6 July 2009
Summary
Thanks for a very helpful review. I am interested in using for my patients, but am puzzled by which program of “rehabilitation” to adopt.
The table of characteristics shows considerable variation, with several combinations, although most seem to be endurance exercise only
rather than a more complex “rehabilitation” program. I was interested in any advice on what program I should implement with my
patients. Could this (and a sample program) be included with the updated review?
Reply
Thank you for this comment. Based on our review, we cannot make any statements about which rehabilitation programmes work best.
However, there are systematic reviews on trials comparing different exercise programs that may help you defining your rehabilitation
programme (e.g. Puhan et al. Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction during respiratory
rehabilitation in COPD patients - a systematic review. Thorax 2005;60(5):367-75).
Contributors
Paul Glasziou
WH A T ’ S N E W
Last assessed as up-to-date: 20 October 2015.
Date Event Description
20 October 2015 New search has been performed This review updates the review published in 2010. We
ran a search on8October 2014, and again on 20October
2015, and ran handsearches up to 5 April 2016
This update identified 11 additional studies (Borges
2014;Deepak 2014;Greening 2014;He 2015; Ko2011;
Tang 2012; Torres-Sánchez 2014; Torres-Sánchez 2015;
Troosters 2010; Ko 2016; Liao 2015) that added 1045
participants. We included in this update a ’Summary of
findings’ table that was based on GRADE and revised
the Discussion section substantially because additional
evidence became available
20 October 2015 New citation required and conclusions have changed Analyses were stratified for how extensive rehabilitation
programmes were because they differed substantially.
The impact of new evidence on patient-important out-
comes gathered for this review update is emphasised in
the revised abstract and review
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H I S T O R Y
Protocol first published: Issue 2, 2005
Review first published: Issue 1, 2009
Date Event Description
10 August 2011 New citation required but conclusions have not
changed
This reviewhas been published as a new citation version
to correct an error by which we omitted this at the last
update. We changed the review author byline at the last
update
12 July 2010 New search has been performed We incorporated posted comments into the review. We
ran a new literature search and included 3 new studies
(Eaton 2009; Carr 2009; Seymour 2010), increasing
the total number of participants from 219 to 432. We
made no changes to the review conclusions
8 April 2008 Amended We converted the review to new review format.
20 February 2005 New citation required and major changes We made substantive amendments.
C O N T R I B U T I O N S O F A U T H O R S
Protocol writing: Puhan, Scharplatz, Gimeno-Santos.
Acquisition of data: Puhan, Gimeno-Santos, Scharplatz.
Analysis and interpretation of data: Puhan, Gimeno-Santos, Scharplatz, Troosters, Cates.
Drafting of manuscript: Puhan.
Critical revision of manuscript for important intellectual content: Puhan, Gimeno-Santos, Scharplatz, Troosters, Cates.
Dr Madlaina Scharplatz (MS) and helped with the previous version of this review, but is not an author of the current version of the
review.
We thank Prof Johann Steurer and Prof Haydn Walters for contributions to previous versions.
D E C L A R A T I O N S O F I N T E R E S T
MA Puhan, E Gimeno-Santos, CJ Cates: no conflicts of interest to declare.
T Troosters conducts research in this field and recruits participants with acute exacerbations into rehabilitation programmes.
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S O U R C E S O F S U P P O R T
Internal sources
• The review authors declare that no internal funding was received for this systematic review, Other.
External sources
• The study authors declare that no external funding was received for this systematic review, Other.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Review authors added risk of bias tables for the 2010 update of this review. We added a ’Summary of findings’ table, along with
specified subgroup analyses on extensiveness of pulmonary rehabilitation programmes, length of follow-up and three indicators of
methodological quality.
We added clarification regarding types of studies: We did not include studies on pulmonary rehabilitation programmes that included
only neuromuscular stimulation or inspiratory muscle training but no physical exercise programme.
In the original protocol, we planned to attempt to obtain data from intention-to-treat (ITT) and per-protocol populations, and to
perform a sensitivity analysis to see whether this made a difference in meta-analysis results; however, the number of trials and the quality
of their reporting did not allow us to compare ITT and per-protocol analyses.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Exercise Tolerance; Disease Progression; Health Status; Hospitalization [∗statistics & numerical data]; Pulmonary Disease, Chronic
Obstructive [mortality; ∗rehabilitation]; Quality of Life; Randomized Controlled Trials as Topic; Resistance Training [methods]
MeSH check words
Humans
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